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ABSTRACT 
     This dissertation explored the racial medication adherence disparity in end-stage renal 
disease (ESRD) patients.  Prior research suggests that there are poor rates of medication 
adherence in the African American ESRD population.  However, the reasons for this 
racial inequity are not understood.  This dissertation explored the impact of everyday 
racism in the healthcare system in general and dialysis centers in particular on medication 
adherence.  To gain an understanding of the possible contribution of everyday racism to 
medication nonadherence, Critical Race Theory (CRT) was used as the theoretical 
foundation of the study.   
     A total of 46 African American ESRD patients participated in the study.  Twenty 
seven patients participated in semi-structured, in-depth interviews.  Some participants did 
explicate that they experienced everyday racism in the healthcare system and such 
experiences impacted their medication adherence.  Additionally, all 46 participants 
completed a survey regarding self-reported medication adherence and everyday racism in 
the healthcare setting.  There was a statistically significant negative relationship between 
the two constructs.  The results of the Pearson’s correlation showed a significant negative 
relationship (r = -.477, p < .01) between medication adherence and everyday racism in 
the healthcare system.   
     This study has several limitations.  A convenience sample was used for both the 
qualitative and quantitative portions.  Additionally, the quantitative study used a 
nonexperimental cross-sectional design with a small sample.  However, this is the first  
vii 
study to ever examine the impact of everyday racism on medication adherence within the 
African American ESRD population.  Furthermore, these results both qualitatively and 
quantitatively suggest that everyday racism did impact the medication adherence of the 
participants.  Thus further study is needed to explore this phenomenon since medication 
nonadherence in the ESRD population results in increased hospitalizations, morbidity, 
and mortality.  
     Further study could result in new information that could be used to generate novel 
interventions to address everyday racism in the healthcare system.  Social workers are 
uniquely qualified given their educational training which focuses on cultural competency 
and their ethical obligation to address social injustice.  Additionally, every dialysis 
patient has a social worker to help them achieve positive health outcomes.  Thus, social 
workers are equipped to work with African American ESRD patients, healthcare 
providers, and dialysis clinicians to design and implement possible future interventions to 
achieve medication adherence racial parity within the ESRD population. 
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CHAPTER 1 
INTRODUCTION
    This dissertation study examined the possible role of everyday racism on the 
medication adherence of African American ESRD patients.  This chapter begins with a 
discussion of the disease process of kidney disease and current treatment modalities.  
Next, the problem statement, purpose of research, proposed conceptual model, and 
research questions are articulated.  The chapter ends with an explication of the proposed 
theoretical foundation of the study, the relevance of the study to social work, and the 
significance of the proposed study to the larger body of scholarly literature. 
Background 
     Chronic kidney disease is the ninth leading cause of death in the US (Centers for 
Disease Control, 2016).  Chronic kidney disease is diagnostically measured in five stages 
with each increasing stage representing a reduction in kidney function (Coresh & 
Eustace, 2008; National Kidney Foundation, 2016).  ESRD is defined as the permanent 
failure of the kidneys and is the fifth and final stage of chronic kidney disease (Coresh & 
Eustace, 2008; Himmelfarb, Chuang, & Schulman, 2008; National Kidney Foundation, 
2016.  The current medical treatment for ESRD is dialysis or kidney transplantation 
(USRDS, 2015).  The majority of African American ESRD patients are on hemodialysis. 
Hemodialysis filters patients’ blood through a dialysis machine (Mayo Clinic Staff, 
2010).  Excess fluids and waste products are collected in the machine.  ESRD patients get 
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dialysis at least three times a week for four to six hours (Browne, 2012).  Hemodialysis 
requires a complex medication regimen and a very restrictive diet.  
     According to the United States Renal Data System (USRDS) (2015), there are 
661,648 prevalent cases of ESRD in the US.  This is a 3.5% increase from 2012 and a 
68% increase from 2000 (USRDS, 2015).  ESRD cases have continued to increase by 
21,000 people every year since 2010 (USRD, 2015).  Of these prevalent cases, African 
Americans are disproportionately represented.  The prevalence of ESRD per million of 
African Americans in the US is 5,584 (USRDS, 2015).  Comparatively, the prevalence of 
ESRD per million of Whites in the US is 1,499 (USRDS, 2015).  Thus, ESRD is nearly 
four times more prevalent among African Americans.   
     There is also marked regional clustering of African American ESRD.  For example, in 
the Southern US, African Americans comprise 50% of the ESRD population (USRDS, 
2015).  This is significant because African Americans represent only 20% of the total 
population in the South (United States Census Bureau, 2011). Furthermore, African 
American ESRD patients are also less likely to successfully manage their medications 
compared to White ESRD patients (Browne & Merighi, 2010; Curtin, Svarstad, & Keller, 
1999; Saran et al., 2003).  However, the reasons for this racial inequity are not 
understood beyond proximal risk factors that include sociodemographic factors (age, 
gender, education, insurance, and income) and other risk factors (pill burden, depression, 
health literacy, patient satisfaction, and health beliefs). 
Problem Statement 
     Medication adherence is defined as “the extent to which patients take medications as 
prescribed by their health care providers” (Osterberg & Blaschke, 2005).  ESRD patients 
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who do not adhere to their medication regimen as prescribed suffer increased 
hospitalizations (Saran et al., 2003; USRDS, 2015), decreased quality of life (USRDS, 
2015), and death (Browne, 2012; Denhaerynck, Manhaeve, Dobbels, Garzoni, Nolte, & 
De Geest, 2007).  African American ESRD patients are less likely to successfully manage 
their medications compared to White ESRD patients (Browne & Merighi, 2010; Curtin, 
Svarstad, & Keller, 1999; Saran et al., 2003).  ESRD patient medication adherence 
disparities are a significant public health problem.   
     Racial disparities in the quality of healthcare African Americans receive are well 
documented.  Compared to Whites, studies have found that African Americans receive 
fewer cardiovascular procedures (Bell & Hudson, 2001; Canto et al, 2000; LaVeist, 
Morgan, Arthur, Plantholt & Rubinstein, 2002; Okelo et al., 2001; Petersen, Wright, 
Peterson, & Daley, 2002; Watson et al., 2001), fewer cerebrovascular tests and 
anticoagulant therapy (Mitchell, Ballard, Matchar, Whisnant & Samsa, 2000; Oddone et 
al., 1999), less comprehensive diabetes care (Baicker, Skinner & Chandra, 2005; Chin,  
Zhang & Merrell, 1998; Heisler, Smith, Hayward, Krein, & Kerr, 2003; Trivedi, 
Zaslavsky, Schneider, & Ayanian, 2005) fewer kidney transplants (Ayanian, Cleary, 
Weissman & Epstein, 1999; Kasiske, London & Ellison, 1998), lower quality hospital 
care (Fiscella & Saunders, 2015; Hasnain-Wynia et al., 2007), and are prescribed less 
pain medication (Heins, Heins, Grammas, Costello, Huang, & Mishra, 2006; Pletcher, 
Kertesz, Kohn, & Gonzales, 2008; Tod, Eaton, D’Adamo & Goe, 2000; Bernabei et al., 
1998).    
     Additionally, some studies have found that African Americans perceive the healthcare 
system as racist, discriminatory, and unjust (Bhattacharya, 2012; Bird, & Bogart, 2001; 
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Hausmann, Jeong, Bost, & Ibrahim, 2008; LaVeist, Nickerson, & Bowie, 2000; Pathman, 
Fowler-Brown, Thaker, Ashkin, Corbie-Smith, 2006; Schlomann & Schmitke, 2007).  
Furthermore, studies have documented that African Americans are suspicious of the 
efficacy of prescribed medications (Lukoschek, 2003; Schrimshaw, Siegel, & Lekas, 
2005; Siegel, Karus, & Schrimshaw, 2000).    
     There is also some evidence in the literature that an association between perceived 
racism/discrimination and medication nonadherence exists within the chronic disease 
context.  Several studies indicate that perceived discrimination is a contributing factor to 
medication nonadherence in African American patients with chronic diseases such as 
type 2 diabetes (Bhattacharya, 2012; Dawson, Walker, Campbell & Egede, 2015), 
hypertension (Forsyth, Schoenthaler, Chaplin, Ogedegbe & Ravenell, 2014; Lewis, 
Askie, Randleman & Shelton-Dunston, 2010; Lukoschek, 2003), and HIV (Bogart, 
Wagner, Galvan, & Banks, 2010; Thrasher, Earp, Golin, & Zimmer, 2008).  However, 
there are no studies that examine how perceived racism/racial discrimination relates to 
medication nonadherence for African American ESRD patients.  Given the racial 
disparity in medication adherence in the ESRD population, the dire physical 
consequences of medication nonadherence, and the existence of racial discrimination in 
the healthcare system, it is important to inquire about the possible role of racial 
discrimination.  
Purpose of Research & Methodology 
     The purpose of this mixed methods dissertation study was two-fold.  The first was to 
conduct a qualitative study comprised of semi-structured in-depth interviews with 
African American ESRD patients regarding possible experience of everyday racism in 
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the healthcare system.  The second was to conduct a correlational quantitative study to 
ascertain if there was a statistical relationship between participants’ medication adherence 
and everyday racism in the healthcare system.   
     A mixed methods approach was chosen for three reasons.  First, in-depth interviews 
allow for the elucidation of nuanced issues that might link racism to medication 
adherence (Creswell & Clark, 2011).  Second, in-depth interviews give participants the 
opportunity to include their voices in the research process.  Third, a quantitative 
component provides a more comprehensive account of the studied phenomenon and 
allows the researcher to build on the information gleaned from the qualitative component, 
thus increasing the credibility of the findings (Creswell & Clark, 2011). 
Qualitative Methods     
     A constructivist grounded theory (CGT) approach guided the interview process and 
data analysis.  CGT was chosen as the methodology because it provides a systematic 
approach to delve into the experiences of everyday life of participants.  CGT also 
acknowledges the impact of the researcher on the research process (Charmaz, 2000, 
2006, 2011).  Therefore, both data collection and analysis are the result of the shared 
experiences and relationships among participants and researcher (Charmaz, 2000, 2001, 
2006, 2011; Charmaz & Mitchell, 1996).  Theoretical understanding occurs when 
researchers ponder, ask old questions, generate new questions, return to the field to gain 
clarification, and make comparisons within the data.  Charmaz (2011) states, “When you 
theorize, you reach down to fundamentals, up to abstractions, and probe into experience.  
The content of theorizing cuts to the core of studied life and poses new questions about 
it” (p.135).  Since the possible role of everyday racism on medication adherence within 
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the African American ESRD population is a phenomenon we know very little about, a 
CGT approach allowed for an in-depth understanding (Charmaz, 2006, 2011).  
Quantitative Methods 
     Data for the quantitative portion of the study was obtained using the two scales: 
Medication Adherence Reporting Scale MARS-5 (see Appendix A) and Discrimination 
in Medical Settings Scale DMS (see Appendix B).  Both scales were administered to each 
participant after the in-depth interview.  It was hypothesized that African American 
ESRD patients who reported high incidences of everyday racial discrimination in the 
healthcare system would report lower adherence to their medication regimen.  The 
statistical test, Pearson’s correlation coefficient, was conducted to statistically test the 
hypothesis.  The Pearson’s correlation coefficient is a measure of the strength of 
association between two variables and is denoted by r.  All statistical tests were 
conducted using the statistical data analysis package SPSS version 24. 
Conceptual Model 
     The conceptual model for this dissertation is presented in Figure 1.1.  Since critical 
race theory (CRT) articulates that racism is ordinary and pervasive throughout society, 
the model begins with racism which is positioned at the top of the model.  Next, everyday 
racism in the healthcare system flows from racism.  This is supported by (Essed’s 1991) 
explication that everyday racism is the everyday manifestation of racism.  Everyday 
racism in the healthcare system is defined as those chronic mistreatments, daily hassles, 
and slights based on membership in a race or ethnic group which African Americans 
experience within the healthcare system (Essed, 1991; Williams & Mohammed, 2010).  
Examples of everyday racism in the healthcare system include being treated with less 
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respect, treated as less intelligent, and not listened to by healthcare providers based on 
your race.  Next, it is posited that everyday racism in the healthcare system leads to 
distrust of the quality and efficacy of prescribed medication.  As mentioned above, 
distrust of the quality and efficacy of prescribed medication has been explicated in the 
literature on chronic diseases other than ESRD (Lukoschek, 2003; Schrimshaw, Siegel, & 
Lekas, 2005; Siegel, Karus, & Schrimshaw, 2000).  Furthermore, it is postulated that 
distrust in medication quality and efficacy work in concert with the identified risk factors 
in the literature to decrease medication adherence.  The variables that are typically cited  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Conceptual Model: Role of Everyday Racism in the Medication 
Adherence of African American ESRD Patients 
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as risk factors include: age, education level, gender, income, insurance, pill burden, 
depression, health literacy, patient satisfaction, and health beliefs (Bame, Petersen, & 
Wray, 1993; Browne, 2012; Curtin, Svarstad, & Keller, 1999; Kalichman, 
Ramachandran, & Catz, 1999; Schmid, Hartmann & Schiffl, 2009). 
Research Questions & Hypothesis 
     Research Questions for Qualitative Portion.  The following research questions were 
addressed: 
1) Do African American ESRD patients experience everyday racism in the healthcare 
setting?   
2) If so, does everyday racism influence their medication adherence?   
3) In what way does everyday racism influence their medication adherence?  
4) If everyday racism does not influence their medication adherence, what does? 
     Hypothesis for Quantitative Portion.  It was hypothesized that African American 
ESRD patients who reported high incidences of everyday racial discrimination in the 
healthcare system would report lower adherence to their medication regimen.   
Definition of Terms  
     ESRD is defined as kidney failure that necessitates dialysis for survival (Hallan & 
Vikse, 2008).  Hemodialysis is the process where a patient’s blood is filtered through the 
dialysis machine to remove excess fluids and waste products (Mayo Clinic Staff, 2010). 
Medication adherence is defined as “the extent to which patients take medications as 
prescribed by their health care providers” (Osterberg & Blaschke, 2005).  Medication 
adherence will be assessed using the Medication Adherence Report Scale (MARS) (see 
Appendix A).   
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     The healthcare system is defined as the particular organizations and staff from which 
the dialysis patients receive care such as the pharmacy and dialysis center.  Staff 
generally includes the following: social worker, dietitian, nurse, nephrologist, pharmacist, 
pharmacy technician, and dialysis technician.  A dialysis clinic is defined as the medical 
setting that hemodialysis patients must attend to receive dialysis on average three times a 
week for three to four hours each day for the rest of their lives.   
     Everyday racism is defined as systematic, recurrent, routine, and normalized 
mistreatment based on a person’s racial group membership (Essed, 1991).  Everyday 
racism can include both mundane annoyances that may be quickly forgotten or severe 
incidences that are never forgotten (Essed, 1991; Feagin & Sikes, 1994; Swim et al., 
1998).  Everyday racism in the healthcare system is defined as those chronic 
mistreatments, daily hassles, and slights based on membership in a race or ethnic group 
which African Americans experience within the healthcare system (Essed, 1991; 
Williams & Mohammed, 2010).  Everyday racism in the healthcare system will be 
assessed using the Discrimination in Medical Settings (DMS) Scale (see Appendix B).   
Theoretical Foundation 
     The theory that informed the approach to understand the possible influence of 
everyday racism on medication adherence is critical race theory (CRT).  The genesis of 
CRT occurred in the 1970’s following the political and legal achievements of the Civil 
Rights Movement.  Two legal scholars, Derrick Bell and Alan Freeman, began to 
question the paucity of economic and societal gains experienced by African Americans 
(Delgado & Stefancic, 2012; Kolivoski, Weaver & Constance-Huggins, 2014).  During 
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this time, many legal scholars, who had been active in the Civil Rights Movement, began 
to critically analyze the US legal system (Constance-Huggins, 2014; Unger, 1983).  
These “radical” legal scholars coined this analysis Critical Legal Studies (CLS) (Delgado 
& Stefancic, 2012; Unger, 1983).   
     CLS scholars asserted that the legal system was neither objective nor just (Hutchinson, 
1989; Unger, 1983).  Instead, they argued that legal ideology, doctrines, and practice 
perpetuated societal inequality through maintaining the status quo which privileged the 
politically and economically powerful (Crenshaw, 1988; Hutchinson, 1989; Unger, 
1983).  Bell and Freeman agreed that political and economic power were important 
factors in maintaining societal inequality.  However, they noted that racism was 
egregiously absent from CLS scholars’ critiques of the legal system (Delgado & 
Stefancic, 2012).    
     Bell and Freeman argued that racism is entrenched and ubiquitous in historical and 
contemporary US society.  Thus, racism is also pervasive in the legal system, which 
necessitates its inclusion in the critique of the legal system.  To do otherwise, they 
contended, perpetuated racial inequality.  Bell (1976, 1979) and Freeman (1977) began 
exploring the relationship among race, racism, and power and publishing their thoughts in 
law journals. They wrote that the ideas of objectivity and fairness attributed to and 
espoused by the legal system were apocryphal and served to mask the invisible privileges 
afforded Whites at the expense of people of color.  They explained that race was not a 
natural category.  Instead it is a social construction used as a tool to establish and 
continue White supremacy in the US.  The resulting racial hierarchy influences legal 
doctrines and practice.  Bell (1976, 1979) and Freeman (1977) asserted that this influence 
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extends to every level of the legal system from local law enforcement to the US Supreme 
Court and the US Constitution.  They postulated that until racism is “unveiled” (Dubois, 
2003), acknowledged, and actively eradicated, it will persist. 
     Soon, like-minded law professors, lawyers, and students engaged in critical discourse 
with Bell and Freeman.  In 1989, the first critical race theory workshop was held in 
Madison, Wisconsin (Delgado & Stefancic, 2012).  Since then critical race scholars have 
urged scholars in disciplines other than law to examine the influence of racism in their 
area of study.  The rationale is that since racism is endemic to society in the US then it 
affects every aspect of society.  Thus, it must impact the educational system, public 
health system, and political system.  As a result of this call to investigate, many other 
disciplines such as education, women’s studies, sociology, political science, and social 
work have become involved in the CRT movement (Delgado & Stefancic, 2012). 
Relevance of CRT to Proposed Research     
     There are several assumptions of CRT that informed this research.  First, CRT 
postulates that racism is an integral part of the social fabric of the United States.  Thus, it 
is conceivable that the African American ESRD patients experience racism in the 
healthcare system.  Second, CRT assumes that racism is an everyday and ordinary life 
occurrence for people of color and determines social outcomes.   CRT scholars refer to 
this ordinariness of racism as the “normal science” of living in US society (Delgado & 
Stefancic, 2012).  This assumption relates to the conceptualization in this study that 
racism influences medication adherence because if racism is an everyday life occurrence 
for African Americans, it is plausible that racism may play a role in their medication 
adherence.  Third, CRT posits that racism is not acknowledged as a problem by the 
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dominant White group.  Since racism is not acknowledged, it is difficult to eradicate.  
This assumption relates to the conceptualization of the racial disparity in medication 
adherence because racism, a distal, societal risk factor, is rarely studied in the field of 
medication adherence.  Instead, the focus is generally on proximal sociodemographic 
factors and behavioral factors.  Sociodemographic factors are generally unchangeable or 
difficult to change such as age, gender, education, and income.  However behavioral 
factors such as depression, pill burden, lack of health literacy, lack of patient satisfaction, 
health beliefs, and social support are often the site for interventions (Browne & Merighi, 
2010; Hu, Juarez, Yeboah & Castillo, 2014; Matteson & Russell, 2010; Simmons-
Morton, McLeroy & Wendel, 2012).  These interventions often put the responsibility on 
the individual African American ESRD patient for the disparity.  The study’s 
conceptualization puts the responsibility on the unacknowledged racism.  The fourth 
concept that was salient to this research is structural determinism.  Structural determinism 
refers to the CRT idea that the racist structure of the US determines, in great part, the 
outcomes of individuals.  This concept relates to the conceptualization of the problem 
because it gives credence to the idea that health outcomes such as medication adherence 
may be influenced by racism in society. 
     There are also three main mandates of CRT that are integral to and guided this 
research.  First, CRT requires that research “centers the margins” (Delgado & Stefancic, 
2012, p.10; Ford & Airhihenbuwa, 2010).  This means that the main focus of research 
using CRT should be the perspectives of people of color; those who have been 
marginalized (Ford & Airhihenbuwa, 2010).  This achieved this mandate through 
eliciting the perspectives of people of color through in-depth interviews.  It was an 
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opportunity for the participants to relate and reflect upon the details of their experiences 
in a respectful context.   
     The second mandate is that it must be understood that people of color have a unique 
voice, a vastly different perspective than White people.  The unique voice of color refers 
to the CRT belief that people of color experienced a different history and currently 
experience a different reality than White people.  Hence, research should not only bring 
the perspectives of people of color to the fore but must acknowledge that their 
perspectives are quite different.  This mandate relates to the conceptualization of the 
problem because to understand the mechanisms of the medication adherence disparity, 
researchers must engage African Americans in how their reality regarding racism, which 
is informed by a history of oppression, impacts their daily lives including their health 
outcomes. 
     The third mandate is that CRT requires social action to challenge racial injustice.  Bell 
and Freeman define social action broadly and include academic publication as a form of 
acknowledging and examining racism.  Although CRT has long been adopted as a 
theoretical and practical stance for education, women’s studies, and political science, 
CRT is a nascent to the field of social work and public health (Ford & Airhihenbuwa, 
2010).  This is the first time to the researcher’s knowledge that CRT has been used to 
examine everyday racism within the African American ESRD population.  Bringing a 
critical analysis to this topic is the beginning of social action as defined by CRT.  
Relevance of Research to Social Work 
     This study is relevant to social work for several reasons.  Fundamentally, nephrology 
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social work with dialysis populations is a critical practice area for the profession, as the 
only Medicare mandate for a Master’s level social worker on treatment teams is found in 
dialysis and kidney transplant centers (Browne, 2012).  Every single dialysis patient has a 
social worker to help them ameliorate the psychosocial barriers to treatment outcomes, 
including medication nonadherence.  The results of this study can help inform 
nephrology social work practice and help dialysis social workers help their patients take 
their medications as prescribed. 
    There is a gap in the social work literature base concerning the possible role of 
everyday racism in the medication taking of African American ESRD patients.  As social 
workers, we are ethically bound to conduct research to elucidate knowledge gaps 
pertaining to issues that affect our clients (NASW, 2008).   Additionally, a foundational, 
core value of the social work profession is social justice.  According to the National 
Association of Social Workers (NASW, 2008), social justice entails “access to needed 
information, services, and resources; equality of opportunity; and meaningful 
participation in decision making for all people” (p. 3).  Furthermore, social workers are 
ethically bound to challenge social injustice in any form including racial oppression 
(NASW, 2008).  Gaining knowledge about a social injustice is the beginning step for 
social change.  Once an injustice is acknowledged, efforts can be made to confront and 
eradicate the injustice.  This study provided the first exploration of racism within the 
healthcare system experienced by African American ESRD.   
Significance of Study      
     Studying medication adherence in the ESRD population is important because the 
disease presents several unique burdens not experienced by patients of other common 
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chronic diseases such as hypertension, diabetes, and HIV.  ESRD patients have the 
highest pill burden (Chiu et al., 2009; Neri et al., 2011; Schmid, Hartmann, & Schiffl, 
2009) and a multitude of body systems are impacted (Brenner, 2008).  Furthermore, 
patients spend much time in the dialysis clinic.  Unlike other mentioned chronic diseases, 
patients with ESRD must dialyze an average of three days per week for three to four 
hours each day and take their medications so they can undergo dialysis without medical 
complications (USRDS, 2015).  If they do not, death is certain.  Thus, ESRD patients 
literally depend on dialysis and their medication regimens for survival.  
     Studying medication adherence in the African American ESRD population is 
important for three reasons.  First, there is a racial disparity in medication adherence in 
the ESRD population.  African Americans adhere less to their medication regimens.  
Second, low medication adherence results in increased mortality, increased 
hospitalizations, and decreased quality of life.  Third, in addition to the burden 
nonadherence creates for the individual ESRD patient, it can be costly.  Almost all ESRD 
patients are enrolled in Medicare when they are diagnosed.  Therefore, taxpayers pay for 
the majority of the care ESRD patients receive in the form of dialysis, hospitalizations, 
and some prescriptions.  If patients do not follow their medication regimens, myriad 
medical complications can occur resulting in expensive medical intervention such as 
hospitalization (Center for Medicare and Medicaid Services, 2014; USRDS, 2015).   
     Fourth, as Bell (1976, 1979) and Freeman (1977) have articulated, African Americans 
have experienced a different history than Whites, a history of subjugation and oppression.  
In addition, the continued presence of racism means that African Americans also 
experience a different reality than Whites.  A reality suffused with racism.  Thus, a 
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critical analysis of medication adherence through the lens of racism is warranted to 
ascertain its possible influence on the medication adherence disparity in the African 
American ESRD population.  Such critical analysis does not currently exist in the 
literature. 
     The following is a review of the extant literature. The literature review includes a brief 
summary of historical racism and discrimination that has occurred in the US in the 
healthcare system in general and towards ESRD patients in particular.  Much historical 
racism and discrimination occurred in the Southern US.  The South was the location of 
the slave economy, Reconstruction, and Jim Crow laws.  The South was also the location 
for the research.  Therefore, much attention is given to abuses that occurred in this locale.  
Furthermore, the intent of this summary is to show the pattern of medical abuses and to 
provide a historical context for the study.   
    Historical context is important to understand because past abuses by the healthcare 
system continue to shape African American ESRD patients’ view of the medical system, 
as mentioned previously (Kennedy, Mathis, & Woods, 2007; Nelson, 2011; Washington, 
2006).  In addition to historical context, the following will be addressed in the next 
chapter: the disease context of ESRD, a discussion of the uniqueness of ESRD, a review 
of the literature concerning the current racial inequities in the healthcare system, 
medication adherence and chronic disease, and racial inequality and medication 
adherence in the ESRD population. 
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CHAPTER 2 
LITERATURE REVIEW
Historical Racial Inequities in Healthcare 
     Slavery.  The current racial inequities in the healthcare system are the result of a 
centuries-long history in which African Americans have been subjected to unequal, 
unethical, and torturous medical treatment and experimentation (Byrd & Clayton, 2000; 
Smith, 1999; Washington, 2006).  This history began even before the first slaves arrived 
in the English colonies in 1619 (Byrd & Clayton, 2000; Washington, 2006).  
     During the Atlantic slave trade, slaves were often kidnapped from the interior of 
Africa and brought to the Western coast of Africa to board slave ships.  Before boarding, 
slaves were physically examined to determine their purchasing worth, their “soundness” 
(Fett, 2002, p.18).  Medical doctors were employed by slave ship owners to conduct these 
inspections at a wage second only to the ship’s captain (Byrd & Clayton, 2000; Fett, 
2002).  Once on the slave ship, however, most doctors did little to ameliorate the 
devastating and brutal conditions slaves experienced during the voyage.  Slaves were, 
“…shackled and stacked like spoons on shelves” (Byrd & Clayton, 2000, p. 195).  They 
were often starved, given stagnant water, and were forced to live in their own urine and 
feces throughout the Middle Passage.  The mortality rate was high ranging from 15 to 80 
percent (Byrd & Clayton, 2000).  Although germ theory did not exist in the 17
th
 century, 
doctors did know that clean water, adequate food, and sanitation practices were essential 
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to health (Blanton, 1972).  However, historical records indicate that doctors did not 
intervene to improve slave ship conditions (Byrd & Clayton, 2000).  Therefore, the vast 
majority of slaves that did survive the Middle Passage arrived in the New World in poor 
health (Blanton, 1972; Byrd & Clayton, 2000).   
     Beginning in 1735 with Linnaeus’ classification of humans in System Naturae, Blacks 
were scientifically classified as an inferior race (Gould, 1996).  This idea soon suffused 
medical science throughout the world including the burgeoning US.  The bodies of slaves 
were considered different from and inferior to White bodies (Downs, 2012; Gould, 1996; 
Lock & Nguyen, 2010; Quraishi & Philburn, 2015; Roberts, 1997).  Medical science 
concluded through experiments and anatomical exploration steeped in racist ideology that 
African Americans compared to Whites had smaller brains (Bean, 1906 ), felt less pain, 
were less resistant to disease, were lascivious (Johnson & Bond, 1934), and had “lower 
mental faculties” (Bean, 1906, p. 411).  An example of such sentiment is Van Evrie’s, a 
medical doctor, (1868) claim that African Americans were so anatomically and 
intellectually inferior to Whites that any attempt to educate them would result in the 
inability of African Americans to walk upright.  Van Evrie (1868) stated, 
     On the contrary, the narrow and longitudinal head of the Negro projecting 
     posteriorally (sic) places his eyes at an angle with the horizon, and thus alone enables 
     him to approximate to an erect position.  Of course, we are not to speculate on what is 
     impossible or to suggest what might happen if the Negro head had resembled that of  
     the Caucasian, for the slightest change of an elementary atom in the Negro structure 
     would render him an impossible monstrosity. But with the broad forehead and small 
     cerebellum of the White man, it is perfectly obvious that the Negro would no longer 
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     possess a center of gravity, and therefore those philanthropic people who would 
     "educate" him into intellectual equality or change the mental organism of the Negro,  
     would simply render him incapable of standing on his feet (p. 93-94).    
     During the 17
th
, 18
th
,
 
and 19
th
 centuries, the slave trade and plantation economy 
flourished in the South.  By 1860 there were four million slaves in the US (Washington, 
2006), 90% of whom were located in the most unhealthy region of the US, the South 
(Washington, 2006).  Disease was endemic to the South and medical science was nascent 
in the 19
th
 century.  However, White plantation owners fared much better than their 
slaves (Savitt, 2002; Washington, 2006).  Slaves were often worked to exhaustion, 
physically and emotionally abused, raped, poorly housed, and often starved (Savitt, 2002; 
Washington, 2006).  Additionally, since physician services were expensive, medical care 
was a last resort (Fisher, 1968; Savitt, 2002; Washington, 2006).  Physicians sometimes 
complained of the harsh conditions slaves endured, but many kept quiet because they 
were dependent on the financial relationship with the slave owners (Byrd & Clayton, 
2000; Washington, 2006).  Physicians commonly contracted their services to plantation 
owners for the care of slaves (Byrd & Clayton, 2000; Washington, 2006).  Thus, 
plantation owners were regarded as the clients as opposed to the enslaved (Byrd & 
Clayton, 2000).  Therefore, most physicians were complicit in the subjugation of 
enslaved African Americans because to do otherwise would result in financial insecurity.  
For example, slave owners often assumed that any sickness was fabricated to enable 
slaves to “malinger” (Washington, 2008, p. 30).  Slavers relied on doctors to confirm this 
assumption.  As a result, doctors sometimes administered caustic chemicals to punish 
slaves complaining of illness or suggested such “medicine” as whipping (Fett, 2002).    
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     Since slaves were regarded as inferior and biologically different from Whites by the 
medical community at the time, especially in the South, “Negro Medicine” was born 
(Byrd & Clayton, 2000; Savitt, 2002).  Physicians in the South, adherent to Linnaeus’ 
theory of race, catalogued “racial traits” that were based on biblical interpretations, 
personal aversion to African Americans, and mythology and called it science (Byrd & 
Clayton, 2000).  Once African Americans were defined “scientifically” as separate from 
and less than Whites, the next step was professionally sanctioned medical 
experimentation (Fauci, 2001; Jones, 1993; Washington, 2006).  African American slaves 
were the victims of experimentation, which included investigating the effects of ether, 
practicing gynecological surgical techniques, pouring boiling water on their spinal 
columns, and leaving them in open pits in the heat of the day to see if new medications 
enabled them to withstand excessive temperatures (Fauci, 2001).  In addition, Southern 
medical schools advertised that students would have ample opportunity to study disease, 
hone surgical skills, and obtain anatomical knowledge for their future medical practice 
due to the availability of slave patients and slave cadavers (Fett, 2002; Washington, 
2006).    
      Such institutionalized and racist ideology led to African American bodies being used 
as objects to test medicines, to practice medical procedures, and to practice surgeries 
even if there were no therapeutic justifications for such actions (Nelson, 2011; 
Washington, 2006). The purpose of medical interventions often was to provide 
information and perfect skills that could be used to treat White patients (Fett, 2002; 
Washington, 2006). 
 
21 
     Emancipation.  After the slave economy in the South was abolished, many newly 
freed slaves were banished from their plantation homes with nowhere to go.  Some found 
shelter in refugee camps with little food and deplorable sanitation conditions.  It is 
estimated that between 25% and 33% of freed slaves died during the first years of 
Reconstruction (Morais, 1967).  However, the federal government’s response to this 
unprecedented suffering was to focus on finding employment opportunities for the freed 
slaves (Downs, 2012).  The prevailing thought was that if freed slaves had jobs, then food 
and better living conditions would lead to better health.   
     The Freedmen’s Bureau was established by the War Department to find such 
opportunities.  With no existing infrastructure to accommodate freed people in the South 
and a resentful White power structure unwilling to provide assistance, the Freedmen’s 
Bureau made deals with existing plantation owners referred to as contract/lease 
arrangements.  The federal government contracted with plantation owners to lease freed 
slaves to the land owners.  The result was that many freed slaves were forcibly taken 
from refugee camps and placed back on plantations.  The plantation owners agreed to 
house and feed some former slaves in exchange for work.  When this occurred, plantation 
owners were loath to provide any services to their new “employees” beyond meager food 
and shelter for their work (Berlin, Glymph, Miller, Reidy, Rowland & Saville, 1990).  
Healthcare in any form was no longer a concern for plantation owners (Downs, 2012).  
Those who could not find work, often women and children, were left homeless, starving, 
and dying of disease (Downs, 2012).  In addition, hospitals refused to care for the newly 
emancipated (Savitt, 2002).  Instead, African Americans were left only to their own 
indigenous folk healing remedies (Downs, 2012; Fett, 2000).   
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     Eventually, because African Americans continued to be excluded from the healthcare 
system, the Freedmen’s Bureau constructed ninety hospitals to serve African Americans 
in the South (Byrd & Clayton, 2000; Fauci, 2001).  However, these hospitals were often 
of little help besides providing temporary food and shelter.  Some hospitals had a limited 
supply of medication and few resources to care for the disease epidemics that occurred 
during Reconstruction.  Even those freed people with jobs could not afford medical care 
such as vaccinations for preventable diseases such as smallpox.   
     In addition, many physicians and White Southerners blamed the former slaves for 
disease epidemics citing the prevailing belief that African Americans were inferior 
biologically (Byrd & Clayton, 2000; Downs, 2012; Fett, 2002; Jones, 1993).  As an 
example, during the smallpox epidemic from 1862-1868 many African Americans did not 
seek help and hid those family members who were sick because they were labeled as 
shameful vectors of disease (Downs, 2012).  Furthermore, there was a fear of the newly 
emancipated that their disease would simply be studied and not ameliorated.  Some 
feared that, “doctors would visit sick former slaves in the name of a so-called cure, but 
were actually motivated by a prurient fascination to observe how smallpox erupted on 
Black skin” (Downs, 2012, p.97).  The smallpox epidemic overwhelmed the Freedmen’s 
Bureau hospitals, and accurate records were not kept.  However, as an example of the 
devastation of the disease, at the height of the epidemic in 1865, 30,000 former slaves 
died in a six-month period in the Carolinas alone (Downs, 2012). 
     Reconstruction ended in 1877.  Republican presidential candidate, Rutherford B. 
Hayes, told Southern congressional Democrats that if he were elected president, he would 
end Reconstruction.  Thus, in exchange for their support, he promised to pull out federal 
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troops from the South.  A deal was struck.  Hayes was elected President and a new era 
began in the South, Jim Crow.  With the federal troops gone from the South, White 
supremacy reigned, and African Americans were subjected again to abuse, 
disenfranchisement, societal exclusion, and death.  Lynchings became societal events 
(Allen & Lewis, 2000; Washington, 2006).  They were sometimes published as upcoming 
events where families gathered to picnic and watch the execution (Allen & Lewis, 2000; 
Ginzburg, 1996).  Families took pictures and sent them as postcards to friends and 
relatives of the lynching they attended.  It was such a frequent occurrence that the US 
Postal System eventually banned the mailing of such postcards in 1908 (Allen & Lewis, 
2000).  The following is a discussion of the medical abuses during Jim Crow. 
     Jim Crow.  During the Jim Crow Era, overt racism remained prevalent in the US.  
African Americans were not permitted in most hospitals in the South and were separated 
from Whites in hospitals in the North (Fauci, 2001; Washington, 2006).  Medical 
experimentation also continued (Byrd & Clayton, 2000; Smith, 1999; Washington, 2006).  
Aubre Maynard, a surgeon at Harlem Hospital, commented on the treatment of African 
Americans by the healthcare system in 1926 (as cited in Smith, 1999): 
     As the helpless slave, as the impoverished freedman following emancipation, as the 
     indigent ghetto resident of today, the share-cropper or dirt farmer of the South, the 
     Negro has always been appropriated as choice “clinical material” by the medical 
     profession.  In the mind of the unregenerate racist, who, unfortunately, has always 
     been represented in the profession the Negro was always next in line beyond the 
     experimental animal.  Without his fate subject to the quality of their skill, and the  
     integrity of their character  He has sometimes benefited from their efforts, but he has 
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     also occupied the role of victim and expendable guinea pig. (p. 24) 
     It is during this time period that one of the most infamous healthcare and medical 
research abuses in US history began, the Tuskegee Syphilis Study.  The study was 
conducted by the United States Public Health System (USPHS).  The purpose of the 
study, which began in 1932, was to ascertain the progression of untreated syphilis in 
African American men living in Macon County, Alabama (Brandt, 1978; Jones, 1991).  
None of the men in the study were informed that they had syphilis until the study was 
stopped in 1972.  In addition, none of the men were ever treated for syphilis even when 
there was an affordable and effective treatment.  Instead, they were studied so that 
doctors could determine how syphilis manifested in the bodies of African Americans.  
Syphilis was considered the new scourge on African Americans, a scourge for which they 
were once again to blame. 
     During Jim Crow, physicians referred to syphilis as the new epidemic plaguing 
African Americans.  African Americans were referred to by the medical community as, 
“a notoriously syphilis-soaked race” (Jones, 1993, p. 27).  As with the other disease 
epidemics, African Americans were blamed for the spread of the disease and thought to 
be especially prone to the disease.  Since syphilis is a sexually transmitted disease, the 
long-held belief in the medical community that African Americans were morally corrupt 
and licentious reemerged as an explanation for the occurrence of the deadly disease 
(Brant, 1978; McHatton, 1906).  This idea was also coupled with the belief that African 
Americans were impossible to medically treat for syphilis.  This sentiment was expressed 
by Dr. Murrell in 1906, 
     Even among the educated, only a very few will carry out the most elementary 
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     instruction as to personal hygiene.   One thing you cannot do, and that is to convince  
     the negro that he has a disease that he cannot see or feel.  This is due to lack of  
     concentration rather than lack of faith; even if he does believe, he does not care; a  
     child of fancy, the sensations of the passing hour are his only guides to the future (as 
     cited in Brandt, 1978, p. 28). 
     Thus it is within this social and medical context that the Tuskegee Study began.  
According to Smith (1999), this context led to three racialized assumptions which guided 
and justified the study.  First, physicians continued to view African Americans as 
biologically different from Whites.  Thus the prevailing thought was that syphilis affected 
the two races differently.  Second, the men were poor, Black, and uneducated; therefore, 
the assumption was that they would not comply with the complex treatment regimen.  
Third, because the men did not have access to medical care, it was assumed that 
participating in this study was better than having no care at all (Smith, 1999). 
     Included in the study were 399 Black men whom researchers knew had been infected 
with syphilis before the experiment.  In addition, 201 Black men who tested negative for 
syphilis were included as the control group (Brandt, 1997; Jones, 1993).  However, the 
researchers never informed the men that they had been tested for syphilis or that they had 
tested positive or negative for the disease.  Instead the men were told they were being 
treated for “bad blood” and would receive free medical care, transportation to and from 
medical appointments, hot meals on the day of medical appointments, and paid burial 
expenses (Brandt, 1978; Jones, 1993).   
     In addition to never informing the infected men that they had syphilis, the researchers 
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consistently lied to the men to ensure that they remained in the study and the maximum 
amount of data could be collected on the progression of the disease.  For example, to 
make sure the men showed up for such painful tests as spinal taps, researchers told them 
they were receiving “special free treatment” (Jones, 1993, p.113).  In addition, the men 
who expected some type of treatment as they were promised were given doses of 
mercurial ointment and neoarsphenamine, which were known to be ineffectual, instead of 
the medically accepted drugs of treatment in 1932, arsphenamine and bismuth (Jones, 
1993).  As the chief physician of the study, Vonderlehr, who was overseeing the 
administration of the ineffectual drugs and tonics, maintained he feared the men would 
not continue to agree to the study if they did not receive some type of treatment.  He 
stated,  
     Expenditure of several hundred dollars for drugs for these men would be well worth  
     while if their interest and cooperation would be maintained in doing so….It is my  
     desire to keep the main purpose of the work from the negroes in the county 
     and continue their interest in treatment.  That is what the vast majority wants and the  
     examination seems relatively unimportant to them in comparison.  It would  
     probably cause the entire experiment to collapse if the clinics were stopped before the  
     work is completed (as cited in Brandt, 1978, p.24). 
     In addition to gaining information from spinal taps, the research team believed that 
only through autopsies could they gain definitive data about the effects of syphilis on 
African Americans.  The researchers realized that autopsies were not deemed culturally 
acceptable by African Americans living in Macon County, Alabama.  As the consultant 
to the study, Dr. Wegner, wrote to Vonderlehr in 1933, 
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     There is one danger in the latter plan and that is if the colored population become  
     aware that accepting free hospital care means a post-mortem, every darkey will leave, 
     Macon County and it will hurt Dibble’s (hospital director) hospital (as cited in Jones,  
     1993, p.134). 
So the researchers decided that the men would have to die in the hospital and 
surreptitiously be autopsied (Jones, 1993).  The researchers reasoned that since the men 
trusted the United States Public Health Service, they would trust Dr. Dibble.  Dr. Dibble 
was the Director of the Tuskegee Institute Hospital and newly appointed to the USPHS.  
He was a government doctor, so the men and their families would not be suspicious.  As 
an added incentive, the USPHS offered to pay for the men’s burials if they died in the 
hospital (Jones, 1993). 
     Once it was discovered that penicillin was a successful treatment for syphilis in 1947, 
treatment was withheld from the men. Throughout the experiment, findings were 
published several times in medical journals (Olansky, Simpson & Schuman, 1954; 
Rockwell et al., 1964; Shafer, Usilton & Gleeson 1954).  However, the experiment was 
not stopped or investigated for withholding treatment.  This is significant since during the 
40 years of the experiment strides were made nationally and internationally to protect 
human rights especially for research participants.  For example, after the medical 
atrocities of the Holocaust, the Nuremburg Code was adopted to protect research 
participants from being forced into experimentation against their will (Mitscherlich & 
Mielke, 2010).  In addition, the Declaration of Helsinki by the World Medical 
Association (1964) mandated that research participants must give informed consent.  
Furthermore, the USPHS blocked any attempts to medically treat the men with syphilis 
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(Brandt, 1978; Jones, 1993).  For example, the Alabama Health Department began a 
campaign in the 1940s to end venereal disease throughout the state.  The agency sent 
medical mobile vans into the rural counties to test and administer medication for venereal 
diseases.  The USPHS told the Alabama Health Department that they were not allowed to 
test or treat the syphilitic men in the Tuskegee Study (Brandt, 1978).  As another 
example, during WWII many of the syphilitic men were drafted.  The men were tested 
and told to begin treatment.  The USPHS intervened.  They explained that the men were 
part of a longitudinal study and asked that they remain untreated.  The draft board agreed 
and no treatment was administered (Brandt, 1978). 
     The Tuskegee experiment abruptly ended in 1972 when a psychiatric social worker, 
Peter Buxtun, who worked for the USPHS informed an Associated Press journalist of the 
experiment.  The information was passed to Jean Heller, a journalist, and published in the 
Washington Star on July 25, 1972 (Jones, 1993, Brandt, 1978).  The Tuskegee 
researchers defended the experiment while the federal government called for an internal 
investigation of the USPHS.  Eventually, due to public outcry, the government assembled 
a nine-member ad hoc panel which gave their results to the Department of Health, 
Education, and Welfare.  The Panel concluded that the study was unethical and the men 
should have been treated with penicillin in the 1940s (Brandt, 1978).  However, there was 
no mention of the basic premise of the experiment, to deny treatment.  As a result of the 
study, 128 men died of syphilis and related complications according to physical 
examinations and autopsies (Jones, 1993; Washington, 2006).  It is important to 
understand the Tuskegee Syphilis Study because for many African Americans it has 
become, “a symbol of their mistreatment by the medical establishment” (Kennedy, 
29 
Mathis & Woods, 2007, p. 56).  A symbol of racism within the healthcare system that has 
been cited by some researchers as one reason for African Americans’ high levels of 
distrust of the healthcare system (Hammond, 2010; Jones, 1993; Kennedy, Mathis & 
Woods, 2007; Shavers, Lynch & Burmeister, 2000).  Thus, since this study is examining 
if everyday racism plays a role in medication nonadherence, understanding the impact of 
past medical abuses endured by African Americans especially as significant and well-
known as the Tuskegee Study is essential. 
     It was also during the Jim Crow Era that the first artificial kidney was invented 
(Friedman, 1998).  Today most patients diagnosed with ESRD are eligible for Medicare. 
ESRD is one of only two chronic diseases (Amyotrophic Lateral Sclerosis is the other) 
that are guaranteed Medicare coverage.  Most persons diagnosed with ESRD have access 
to dialysis only because their dialysis costs are covered through Medicare (Medicare, 
2011).  This coverage has not always been provided.  When the process of dialysis was 
invented, it was viewed as experimental and funded primarily through donations and the 
private funds of patients (Browne, 2012; Peitzman, 2001).  There were many more ESRD 
patients needing treatment than available dialysis machines or funds to pay for treatment 
expenses.  As a result, dialysis was rationed.  Rationing is the allocation of a needed, yet 
scarce, resource (Jonsen & Edwards, 2010).  The end result of rationing is that some 
people receive the resource and others do not.  In the case of kidney dialysis, treatment 
was allocated based on medical suitability and judged social worth of the patient.  The 
following is a discussion of the history of dialysis and the impact of racial inequality.  
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Historical Racial Inequity & ESRD 
     Willem Kolff invented the first artificial kidney in 1943 that made dialysis possible 
(Friedman, 1998).  The artificial kidney unit was expensive to produce and maintain, thus 
few were created (Friedman, 1998).  The artificial kidney required physical access to the 
circulatory systems of patients (Friedman, 1998).  Thus, patients were surgically 
connected to the artificial kidney.  Surgical connections were only feasible for short-term 
use due to the possibility of surgical wound infections (Friedman, 1998).  Given these 
constraints, Kolff and the medical community envisioned the artificial kidney as only 
useful for patients suffering from acute renal failure who would recover with a few 
treatment sessions and had the ability to pay for the expensive treatment (Friedman, 
1998).  Hence, African Americans, who were relegated to substandard medical care 
during this time period, if they were provided care at all, were not considered for 
treatment.   
     In 1960, Scribner revolutionized kidney dialysis with his invention of the dialysis 
shunt (Peitzman, 2001).  The shunt was a device surgically inserted under the skin of the 
forearm which allowed constant access to patients’ circulatory systems (Peitzman, 2001).  
This technological advancement meant that dialysis could be offered to patients with 
chronic kidney disease on an outpatient basis.  However, dialysis was still quite 
expensive.  In the early 1960s, the cost of dialysis was $15,000 per person per year 
(Fetherstonhaugh, 2009).  Scribner obtained funding from the Hartford Foundation and 
began offering community dialysis through the Seattle Artificial Kidney Center (SAKC) 
in 1962 (Peitzman, 2001).  The SAKC was the pioneer community dialysis center.  Upon 
opening, the SAKC was inundated with ESRD disease patients in need of dialysis.  In the 
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early 1960s, it was estimated that 40,000 people were dying a year from ESRD 
(Fetherstonhaugh, 2009).  To choose who would receive dialysis, Scribner and his 
colleagues devised a two-tiered patient selection system.  The first tier of the selection 
process was based on the following criteria:   
     They had to be stable, emotionally mature, uremic adults under the age of 45, without 
long-standing hypertension and vascular complications, willing to cooperate with the     
dialysis regimen and low protein/low sodium dietary regimen, and with stable or slowly 
deteriorating renal function (Blagg, 2007, p. 485). 
     The medical criteria also included a psychological assessment to ascertain if the 
patient had the ability to “…take an active role in their own well-being; have the potential 
for rehabilitation” (Fetherstonhaugh, 2009, p.89).  Rehabilitation was defined by the 
doctors as having the potential to be a productive citizen and live a “useful life” 
(Fetherstonhaugh, 2009, p.89).  Furthermore, young adults who could not financially 
support themselves were rejected.  Children were not considered candidates for dialysis 
for two reasons.  First, the procedure presented too many complications with children, 
and Scribner and his colleagues wanted those patients with the best chances of survival to 
receive dialysis (Blagg, 2007).  Second, those at SAKC making the selection decisions 
thought it unfair to allow a child to receive dialysis and deny dialysis to a patient who 
was the head of a household consisting of many children (McGough, Reynolds, Quinn, & 
Zenilman, 2005).   
     The second tier of the selection process involved the Admissions and Policies 
Committee.  This was an anonymous committee comprised of seven community 
members that included, “…lawyer, a minister, a banker, a housewife, an official of state 
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government, a labor leader and a surgeon” (Alexander, 1962, p. 107).  The committee 
members were also described as being White, Protestant, middle class citizens (McGough 
et al., 2005).  The task of the committee was to make final patient selection decisions.  
The committee based their decisions on many patient factors including level of education, 
marital status, net worth, work performance and history, and number of dependents 
(McGough et al., 2005).  The committee selected patients who they thought had the most 
promising potential to remain, or soon become, productive community members 
(McGough et al., 2005).  The committee based their decisions on how important they 
thought each applicant was to the community (McGough et al., 2005).   In other words, 
they used social worth as their standard of measure. 
     For the committee members, social worth was narrowly defined by their Protestant, 
White, middle-class value system.  This is evidenced by the patients that they chose to 
receive dialysis.  The committee overwhelming chose men who were White, married with 
many children, active in church and the community, had a history of positive 
performance at work, and were middle class to receive dialysis (Blagg, 2007; 
Fetherstonhaugh, 2009; McGough et al., 2005).  No African American was chosen for 
dialysis during this time even though they were a growing segment of Seattle’s 
population (Peitzman, 2001; Seattle Municipal Archives, 2016).  After World War II 
many African Americans moved North and West in search of employment, and Seattle 
was a popular destination (Seattle Municipal Archives, 2016).  The African American 
population in Seattle increased from 1% in 1940 to 4.8% in 1960 (Seattle Municipal 
Archives, 2016).  Lastly, it is important to keep in mind that those who were not chosen 
for dialysis, those who did not correspond to the committee’s values, died. 
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     Months after the SAKC began providing outpatient dialysis, Shana Alexander (1962) 
wrote an article for Life magazine (Blagg, 2007).  In the article, she described SAKC’s 
mechanism for dialysis allocation.  The public was appalled that patients were selected to 
live because of their apparent usefulness to society (Blagg, 2007).  Interestingly, the 
medical criteria, although scrutinized today, was considered at inception to be value-free 
and without bias.  The outrage that ensued focused on the fact that women, children, and 
older adults were not eligible for dialysis given the social worth criteria (Blagg, 2007).   
However, there was no documented outrage that no African American had received 
dialysis (Peitzman, 2001).  Thus in 1972, women, children, and elders meant White 
women, White children, and White elders.  On October 30, 1972, President Nixon signed 
the bill establishing the ESRD Medicare program (Blagg, 2007).  This bill ensures that no 
ESRD patient can be denied dialysis based on inability to pay for services or social worth 
criteria.  However, although dialysis cannot be denied to African American ESRD 
patients, racial inequities do presently exist within the ESRD population,  
     Dialysis and the current system of healthcare for ESRD patients takes place within the 
context of the biomedical model.  The following is a discussion of this model and the 
current racial inequities that occur in the healthcare system and racial inequities as they 
pertain to medication adherence in the chronic disease population.  Additionally, the 
uniqueness of ESRD as a disease, the extraordinary burden of medication adherence 
within this population, and the current racial inequity in the medication adherence of 
ESRD patients will be examined.   
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The Biomedical Model  
     Today, hemodialysis and medication adherence are medical treatments that occur 
within the parameters of the prevailing model of medicine in the US, the biomedical 
model.  The biomedical model privileges the technical understanding of the pathology of 
disease and its effects on patient physiology (Annadale, 1998; Wade & Halligan, 2004).  
The anatomical body is separated from the social and psychological body and subjected 
to scientific examination (Annadale, 1998; Wade & Halligan, 2004).  Thus, the medical 
provider is the expert who prescribes treatments and medication to be absorbed by 
patients with little input or inquiry from patients (Mykhalovskiy, McCoy, & Bresalier, 
2004).   
     In addition, when patients do not take their medication as directed, medical providers 
often engage in repressive attempts to cajole or scare patients into following their 
directions (Mykhalovskiy, McCoy, & Bresalier, 2004).  Accordingly, patients are 
effectively silenced.  This model is particularly salient to African American consumers of 
healthcare.  As discussed earlier, for centuries African Americans have been subjected to 
a racialized healthcare system (Byrd & Clayton, 2000; Fisher, 1968; Nelson, 2011; Savitt, 
2002; Smith, 1999; Washington, 2006).  However, the racial inequities within the 
biomedical structure of healthcare provision are not simply reserved for the past.  Today, 
racial inequities of care continue.  The following is a discussion of the current unequal 
medical treatment of African Americans within the racialized context of healthcare in the 
US.  
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Current Racial Inequities in Healthcare 
     Research suggests that patients’ race and ethnicity influences physicians’ diagnostic 
evaluations and treatment decisions, as well as their feelings about patients (Green, 2007; 
Smedley, Stith, & Nelson, 2002; US Department of Health and Human Services, 2014; 
Van Ryn & Burke, 2000).  For example, Green and colleagues (2007) found in their 
study of 220 physicians that physicians’ implicit bias was associated with differences in 
treatment recommendations for patients presenting with myocardial infarctions.  In 
addition, Van Ryn and Burke (2000) conducted a study of physicians’ perceptions of 
post-angiogram patients.  The study involved 193 physicians who reported on 618 patient 
encounters.  The authors found that patient ethnicity was associated with a number of 
negative assessments of patients.  Specifically physicians rated African American 
patients as less intelligent, more likely to engage in risky behaviors, less educated, less 
likely to adhere to medical advice, and less likely for physicians to feel affiliation 
towards compared to White patients (Van Ryn & Burke, 2000).  Similarly, the 2014 
National Healthcare Disparities Report indicates that White patients receive better quality 
of healthcare than African Americans patients (US Department of Health and Human 
Services, 2014).    
     Studies also show that African Americans are aware of the racial biases of healthcare 
providers and report racial discrimination occurring in interactions within the healthcare 
system more than Whites (Hausmann, Jeong, Bost, & Ibrahim, 2008; Hausmann, Kressin, 
Hausa, & Ibrahim, 2010; LaVeist, Nickerson & Bowie, 2000; Peek, Wagner, Tang, Baker 
& Chin, 2011; Shavers et al., 2012; Sorkin, Ngo-Metzger, & De Alba, 2010).  For 
example, LaVeist, Nickerson and Bowie (2000) found in a sample of 1,784 cardiac 
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patients that 30% of African American patients reported that racial discrimination in a 
doctor’s office is common compared to 7.3% of Whites.  Another study found that 10.9% 
of African Americans reported perceived racial discrimination in the healthcare system 
compared to 2% of Whites (Hausmann, Jeong, Bost, & Ibrahim, 2008).   
     Thus, the experience of current racial discrimination coupled with a centuries-old 
history of invidious medical abuses is postulated to lead to distrust of the healthcare 
system among African Americans (Boulware, Cooper, Ratner, LaVeist, & Powe, 2003; 
Freedman, 1998; Kennedy, Mathis, & Woods, 2007; LaVeist, Nickerson & Bowie, 2000; 
LaVeist, Morgan, Arthur, Plantholt, & Rubinstein, 2002).  For example, Freedman (1998) 
conducted a qualitative study with 13 African American women and found that the 
participants worried that their certain health issues were “often over-looked by White 
physicians'” (p.943).  Kennedy, Mathis, and Woods (2007) echo this sentiment stating, 
“Distrust of the health care system by African Americans runs from the feelings of ill 
gains for participation in clinical trials to being used only as guinea pigs” (p. 57).  
Furthermore, distrust of the healthcare system because of racism has been linked to less 
utilization of medication (Finnegan et al., 2000; Fiscella, Franks, Gold, & Clancy, 2000; 
LaVeist, Nickerson, & Bowie, 2000; Paradies, 2006; Van Houtven et al., 2005).   
Racial Inequity, Medication Adherence and Chronic Disease 
    There is a large literature base regarding medication adherence and chronic disease 
with evidence that African Americans exhibit low medication adherence (Barton, 2009; 
Halkitis, Palama, & Mukherjee, 2008; Shenolikar, Balkrishnan, Camancho, Whitmire, & 
Anderson, 2006).  For example, Shenolikar, Balkrishnan, Camancho, Whitmire, and 
Anderson (2006) conducted a study to ascertain levels of medication adherence in a 
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sample of participants who were diabetic.  The authors found that the rates for adherence 
to diabetic medications were 12% lower for African Americans compared to Whites 
(Shenolikar, Balkrishnan, Camancho, Whitmire, and Anderson, 2006).  Similarly, 
Halkitis, Palmar, and Mukherjee (2008) found that African American men were less 
adherent to their antiretroviral medication regimen than Hispanic and White men in their 
study.  Although these studies measured medication self-management, they did not 
examine the possibility that perceived racism contributes to the lower adherence rates in 
their samples. 
     Additionally, there are a few studies that have shown a link between racial 
discrimination experiences and medication adherence with patients diagnosed with 
diabetes (Bhattacharya, 2012; Dawson, Walker, Campbell & Egede, 2015), hypertension 
(Cuffee et al., 2013; Forsyth, Schoenthaler, Chaplin, Ogedegbe & Ravenell, 2014; Lewis, 
Askie, Randleman & Shelton-Dunston, 2010; Lukoschek, 2003), and HIV (Moore, 
Stanton, Gopalan, & Chaisson, 1994; Shapiro et al., 1999; Siegel, Karus & Schrimshaw, 
2000).  For example, Kressin et al. (2010) showed in their sample of 806 hypertensive 
African Americans that those who reported more racial discrimination experiences were 
less adherent to their hypertensive medication regimen.  Similarly, Cuffe et al. (2013) 
found that perceived racial discrimination was associated with lower medication 
adherence in their sample of 780 African American men and women with hypertension.  
Lastly, in a study of 134 hypertensive African American men and women, the author 
found a negative association between high levels of perceived racism and medication 
adherence (Daramola, 2009). 
38 
     However, there are few medication adherence studies of patients with ESRD and even 
fewer studies that have measured medication adherence in the African American 
population (Curtin, Svarstad, Andress, Keller, & Sacksteader, 1997; Curtin, Svarstad, & 
Keller, 1999; Leggat et al., 1998; Saran et al., 2003).  Additionally, no studies have 
examined the possible influence of everyday racism on medication nonadherence. This is 
troubling since the results of medication nonadherence for ESRD patients are increased 
hospitalizations (Saran et al., 2003; USRDS, 2015), decreased quality of life (USRDS, 
2015), increased morbidity (USRDS, 2015), and death (Browne, 2012; Denhaerynck, 
Manhaeve, Dobbels, Garzoni, Nolte, & De Geest, 2007).  
Uniqueness of ESRD 
     ESRD is a uniquely burdensome disease.  ESRD has profound negative effects on 
many organ systems, results in high rates of mortality and hospitalization, and is costly.  
With the failure of the kidneys, many systems in the body are affected leading to an array 
of physical ailments.  ESRD patients may suffer from bone fractures and pain, anemia, 
high blood pressure, neuropathy, blood glucose problems, cardiovascular problems, liver 
failure, congestive heart failure, hyperparathyroidism, increased risk of infections, 
malnutrition, muscle pain, dementia and brain dysfunction, stomach and intestinal 
bleeding, electrolyte imbalance, and seizures (Brenner, 2008).  For many ESRD patients, 
fluid can leak from the pores in their skin and crystallize causing unremittingly itchy skin 
and infections (Berger & Steinhoff, 2011).  Others cannot get relief from restless legs 
(Gigli et al., 2004), and some experience such extreme fatigue that getting out of bed is a 
challenge (Jhamb, Weisbord, Steel & Unruh, 2008).   
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     Given the severe effects of ESRD, dialysis patients have significantly higher mortality 
and fewer expected remaining life years than the general population.  The average life 
expectancy for a person on dialysis is five to ten years after initial diagnosis (NKF, 
2016).  Dialysis patients younger than 80 years old have a life expectancy less than one 
third as long as those without ESRD (USRDS, 2015).  Furthermore, ESRD patients 80 
years old and older have a life expectancy less than one half as long as those without 
ESRD (USRDS, 2015).  ESRD patients in general also have significantly higher 
mortality rates than other Medicare populations with chronic diseases such as diabetes, 
cancer, or cardiovascular disease (USRDS, 2015).  For example, mortality rates for 
ESRD are 1.7 times higher than heart failure patients and 4 times higher than diabetic 
patients (USRDS, 2015).  Lastly, there are ethnic differences in mortality rates.  African 
American and White ESRD patients younger than 45 years old have similar mortality 
rates.  However, older White ESRD patients have higher mortality rates compared to 
African Americans.   
     ESRD patients also suffer high rates of hospitalization for many reasons including 
vascular access, infections, and cardiac events.  ESRD patients must endure many 
procedures to achieve vascular access for dialysis.  A catheter, arteriovenous (AV) 
fistula, or AV graft provides vascular access.  African Americans overwhelmingly choose 
AV fistulas (Iacono, 2004).  Unfortunately, there is a 35.9% failure rate for AV fistulas 
with African Americans experiencing the highest failure rates (Dember et. al., 2014).  
ESRD patients are also hospitalized nearly two times a year for a total of 11.2 days per 
patient year (USRDS, 2015).  Furthermore, when ESRD patients are compared to 
Medicare patients who do not have ESRD, those with kidney failure are hospitalized 
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more than twice as much.  Lastly, African Americans experience higher rates of 
readmission to the hospital and death within 30 days of hospital discharge compared to 
Whites.   
     In addition to the burdens suffered by individuals with ESRD, there are profound 
monetary costs involved for society.  The annual cost incurred by Medicare for ESRD 
patient care is $29 billion (USRD, 2015).  To put that in perspective, total Medicare 
spending was $618.7 billion in 2014 (Center for Medicare and Medicaid Services, 2014).  
Moreover, Medicare spends $70,000 on average for each ESRD patient compared to 
$9,523 spent on average for each Medicare recipient without ESRD (Center for Medicare 
and Medicaid Services, 2014).  Therefore, a significant portion of Medicare is allocated 
to less than 1.3% of Medicare recipients.  Furthermore, as mentioned above, ESRD 
patients experience frequent hospitalizations.  Hospitalizations of ESRD patients account 
for 40% of the entire Medicare budget for ESRD patients (Center for Medicare and 
Medicaid Services, 2014; USRDS, 2015).   
     ESRD is a debilitating chronic disease that poses an extraordinary burden for patients 
both individually and societally irrespective of race.  However, there is evidence of racial 
disparities in quality of care and access to care for patients with ESRD.  The following is 
an explication of the unique burdens of ESRD and evidence of racial disparities. 
Burdens of ESRD & Medication Adherence 
     Medication adherence is uniquely challenging for ESRD patients.  ESRD patients 
have the highest pill burden when compared to patients suffering from all other chronic 
diseases (Chiu et al., 2009).  Due to the multiplicity of organ systems affected by ESRD, 
patients must take numerous types of medication.  When the kidneys fail, the ability to 
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metabolize minerals is affected.  Thus, myriad medications are needed to control 
phosphorous, calcium, and vitamin D (Brenner, 2008).  Also, AV fistulas usually require 
multiple, painful surgeries and can result in chronic pain (Iacono, 2004).  Sixty percent of 
ESRD patients suffer from chronic pain, which may lead to a decrease in quality of life 
(Iacono, 2004).  Of ESRD patients with chronic pain 66% take prescription pain 
medication to control the pain, which adds another medication to an already complex 
regimen (Iacono, 2004).   
     On average, ESRD patients are required to take 6-12 pills per day; however, 25% of 
ESRD patients take 25 pills or more per day (Chiu et al., 2009; Schmid, Hartmann, & 
Schiffl, 2009).  Also, pills are often difficult to swallow due to fluid restrictions, they 
often result in side effects such as nausea and vomiting, and some are extremely large in 
size (Chiu et al., 2009; Lindberg & Lindberg, 2008; Schmid, Hartmann, & Schiffl, 2009; 
Walker et al., 2006).  Moreover, if laboratory results indicate that medication adherence 
is unsuccessful, ESRD patients may be prescribed more pills, further increasing their pill 
burden (Chiu et al., 2009).  In addition to the sheer number of pills, negative side effects 
of the medication, and difficulty of ingesting pills, the medication regimen is complex.  
For example medication must be taken at different times throughout the day and are 
dependent on meals and fluid intake.  Thus, it is difficult to establish a daily routine, and 
this complicates an already complex medication regimen.   
     Additionally, ESRD patients are often financially responsible for a portion of their 
medication expenses.  ESRD patients’ average out-of-pocket expense for medications per 
year is $119 for patients with low income subsidy (LIS) and $1,106 for those who do not 
have the subsidy (USRDS, 2015).  This is higher than the general Medicare population 
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out-of-pocket cost, which ranges from $105 for low income subsidy patients to $590 for 
patients who do not qualify for a subsidy (USRDS, 2015).  This can be a substantial 
hardship since patients often cannot work given treatment demands (Hirth, Greer, Albert, 
Young, & Piette, 2008).   
     In addition to the personal burden posed by medication, it is also costly to taxpayers.  
Since all ESRD patients are eligible for Medicare coverage when diagnosed, the majority 
(74%) of ESRD patients participate in the federal government’s Medicare Part D 
Prescription Drug Coverage Plan (USRDS, 2015).  For example, in 2013, per patient per 
year Medicare Part D spending for ESRD patients ($6,673) was 2.6 times higher than for 
general Medicare patients ($2,592) (USRDS, 2015).   
     In summary, the treatment for ESRD poses an extraordinary physical and monetary 
burden for patients irrespective of race.  If patients do not adhere to treatment, the results 
include increased hospitalizations, morbidity, and death (Brenner, 2008; Browne, 2012).  
Thus given the gap in the literature regarding medication adherence amongst African 
American ESRD patients coupled with the unique burdens of ESRD, it is imperative to 
study the particular factors that influence medication adherence in this population. 
Racial Inequity, Medication Adherence & ESRD   
     Few studies concerning ESRD patients have investigated the racial inequity in 
medication adherence.  The majority of studies that have included ethnicity as a variable 
suggest that African American ESRD patients are less adherent compared to White 
ESRD patients (Curtin, Svarstad, Andress, Keller, & Sacksteader, 1997; Curtin, Svarstad, 
& Keller, 1999; Leggat et al., 1998; Saran et al., 2003).  For example, Leggat and 
colleagues (1998) found in their study of 6,251 hemodialysis patients that being African 
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American was a predictor of nonadherence.  Furthermore, Curtin, Svarstad, and Keller 
(1999) found in their study of African American and White ESRD patients that only 
race/ethnicity was significantly associated with poor medication adherence.  Specifically, 
60% of African Americans were repeatedly nonadherent compared to 34% of Whites 
(Curtin, Svarstad, & Keller, 1999).  Similarly, Saran et al. (2003)  in their study of 8,396 
ESRD patients found that African Americans were twice as likely as Whites to be 
nonadherent (Saran et al., 2003).  Although, Curtin, Svarstad, & Keller (1999) and Saran 
et al., (2003) note that racism and discrimination may be a factor and urge researchers to 
study these constructs, no study has examined if perceived racial discrimination 
contributes to these disparities in medication adherence.   
     The following is a description of the methodology for the proposed research.  To gain 
an understanding of the possible contribution of everyday racism to medication 
nonadherence, I use Critical Race Theory (CRT) as the theoretical foundation of the 
mixed methods study.  CRT postulates that racism is endemic to US society and affects 
every aspect of society.  I also propose to use the conceptualization of everyday racism 
by Essed (1991).  Essed (1991) defines everyday racism as the manifestation of structural 
racism.  The “everyday” is the context where the broader, structural racism occurs.  
Lastly, I will use both semi-structured, in-depth interviews and two scales, MARS-5 and 
DMS, to collect data.  The qualitative portion of the study will be guided by CGT during 
data collection and analysis.  For the quantitative portion, a correlations analysis will be 
conducted to ascertain if there is a relationship between the two constructs within the 
study sample.  
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CHAPTER 3 
METHODOLOGY
     The research study was reviewed and approved by the Institutional Review Board 
(IRB) at the University of South Carolina for Human Subjects approval before 
implementation.   
Mixed-Methods Design 
     The research used a mixed-methods approach comprised of an exploratory qualitative 
study and a correlational quantitative study informed by Critical Race Theory to 
understand 1) if a statistical relationship existed between everyday racism and medication 
adherence and 2) how and to what extent everyday racism may have impacted the 
medication taking behavior of participants.  This design was chosen because a gap in the 
literature currently exists regarding the racial medication adherence disparity within the 
ESRD population.  The disparity in medication adherence within the African American 
ESRD population is a phenomenon of which little is known.   
     Additionally, no literature examines the possible role of everyday racism; therefore, a 
mixed methods study of the phenomenon enabled a more comprehensive exploration.  
This study used semi-structured, in-depth interviews and two surveys for data collection.  
For the qualitative portion, a Constructivist Grounded Theory was employed as the 
method for data analysis and development of theory.  For the quantitative portion, 
Pearson’s correlation analysis was conducted to ascertain if there was a statistical 
relationship between everyday racism in the healthcare setting and medication adherence.  
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The following is a discussion of sampling sites, recruitment, procedures, measures, and 
analyses methodology. 
Sampling Sites 
     Currently, the vast majority of dialysis clinics in the US are owned by two large for-
profit corporations, Fresenius Medical Care and DaVita (Sullivan, 2010).  Since 1991, the 
for-profit dialysis industry has increased four-fold and dominates the healthcare market 
for those with ESRD (Sullivan, 2010).  Given the corporate environment of dialysis 
clinics, it is quite difficult to obtain approval to conduct research on-site.  Corporations 
usually cite patient confidentiality concerns and fear that the research will have negative 
implications for the company. 
     Due to the difficulty of conducting this study at dialysis clinics, African American 
ESRD patients who attended the National Kidney Foundation (NKF) Patient 
Empowerment Meeting (PEM) in North Carolina and South Carolina, and the American 
Association of Kidney Patients (AAKP) National Meeting in Tennessee comprised the 
sample.  These events are designed for kidney dialysis patients and transplant patients 
across the South.  The meetings offer kidney patients new information about kidney 
disease, dialysis, transplantation, the healthcare system, and dietary tips (NKF, 2016).  
Additionally, kidney patients can share their personal stories in a group forum and 
network with other kidney patients and kidney professionals (NKF, 2016).   
     These events were chosen as the setting for this study for three reasons.  First, many 
members of the meetings are African American.  Thus, there was a greater probability of 
obtaining enough interviews to reach saturation.  Second, these meetings are independent 
of any dialysis clinic or dialysis corporation, and participants may be more willing to 
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discuss sensitive issues related to their dialysis clinic, pharmacy, and healthcare system if 
they are not being interviewed in such settings.  Third, the meetings took place in the 
South, which is the area of interest for this study. 
Recruitment  
     Convenience sampling was used at both conference locations.  The researcher worked 
closely with the meeting organizers.  The researcher made an announcement at the 
beginning of each meeting informing the attendees of the purpose of the research.  
Initially criterion sampling was used.  Those participants who met the following inclusion 
criteria and agreed to participate were obtained for the study: 1) African American aged 
at least 18 years 2) Diagnosed with ESRD and on dialysis 3) Have physical stamina to 
engage in an interview 4) Speak English.   
     There are several reasons for the chosen inclusion criteria.  First, participants in this 
study were African ESRD patients because of the focus of the research.  Both females 
and males made up the sample.  Second, participants were 18 years old and older.  
Children, those less than 18 years old, were not included in this study.  ESRD is 
relatively rare in children as compared to adults.  In addition, most children are not 
developmentally capable of independently adhering to a medication regimen.  Therefore, 
parents or guardians are responsible for medication adherence in children.  Hence if 
children were included this would be an entirely different study as I am interested in how 
racism in the healthcare system may influence medication taking behavior in African 
American ESRD hemodialysis patients.  Although children with ESRD may experience 
and perceive racism in the healthcare system, they rarely are given the choice to make 
decisions to adhere or not.  Instead, parents and guardians usually manage children’s’ 
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medication taking.  Third, ESRD is a severely debilitating disease, and a one- to two-hour 
interview can be exhausting for those without a chronic disease.  Therefore, each 
participant was asked if she/he had the energy to be interviewed during the informed 
consent process.  Fourth, the ability for each participant to speak English was a necessity, 
in that we chose to focus on English-speaking populations given limited funds for hiring 
an interpreter.   
Procedures 
     In-depth interviews are defined as “a conversation with a purpose” (Kahn & Cannell, 
1957, p.149).  In-depth interviews were employed because they enabled the researcher to 
elicit participants’ beliefs, views, assumptions, and feelings in an effort to understand and 
explore the meaning that participants ascribed to everyday occurrences (Charmaz, 2006; 
Creswell, 2013).  Furthermore, in-depth interviews allowed the researcher to obtain 
clarification of such meanings and to obtain a large amount of data in a relatively short 
amount of time (Marshall & Rossman. 1994).   
     Data were collected, transcribed, and analyzed using CGT methods of initial coding 
producing categories.  These categories were elaborated through questioning, memo 
writing, comparison of categories, and deep thought.  Data were gathered and analyzed 
until no new properties of the constructed categories emerged.  At this point, the 
categories were considered saturated (Charmaz, 2006). 
     Twenty seven interviews were conducted lasting 20 minutes to approximately two 
hours.  Theoretical saturation is difficult to predict before data collection begins and 
initial analysis occurs.  Charmaz (2006) tentatively advises that 25 interviews may be 
sufficient.  Creswell (2013) suggests 20 to 60 interviews may be sufficient.  Ritchie, 
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Lewis, and Elam (2003) and Green and Thorogood (2009) propose that 20 interviews 
may be sufficient.  Given the nebulous nature of theoretical saturation, the researcher 
worked closely with her committee chair and discussed theoretical insights, and when it 
seemed that collecting more data did not explicate constructed categories. 
     Data was collected using two surveys: MARS-5 and DMS scales (described below), a 
demographic questionnaire, and a series of interview prompts.  The surveys were 
administered after the interviews to guard against priming the participants.  Surveys were 
also available for participants who do not engage in the interviews.  Interviews were 
recorded using an audio recorder and labeled numerically.   
Measures 
Demographic Survey.  Sample characteristics measured included gender, age, level of 
education completed, type of insurance, and number of pills taken daily (see Appendix 
C).   
Medication Adherence Reporting Scale.  Medication adherence was measured 
quantitatively using the Medication Adherence Reporting Scale (MARS-5) (see 
Appendix A).  The scale score was conceptualized as an ordinal variable which was 
analyzed at the scale level of measurement.  MARS is a 5-item self-report scale which 
yields a single scale score ranging from 5 to 25.  Each item is comprised of five points 
where 5=never, 4=rarely, 3=sometimes, 2=often, and 1=very often.  Higher scores 
indicate higher levels of self-reported adherence. The MARS has shown adequate 
reliability with a Cronbach’s α = 0.85 (Horne & Weinman, 2002).  The measure has also 
been shown to exhibit construct validity as evidenced by a moderate correlation (r=.53) 
with an asthma drug count (Ohm & Aaronson 2006).   
 49 
Discrimination in Medical Settings Scale.  Everyday racism in the healthcare system 
was measured using the Discrimination in Medical Settings scale (DMS) (see Appendix 
B).  The scale score was conceptualized as an ordinal variable which will be analyzed at 
the scale level of measurement.  The DMS Scale is a 7-item self-report scale which yields 
a single scale score ranging from 7 to 35 (Peek, Nunez-Smith, Drum, & Lewis, 2011).  
Each item is comprised of five points where 5=always, 4=most of the time, 3=sometimes, 
2=rarely, and 1=never (Peek, Nunez-Smith, Drum, & Lewis, 2011).  The Discrimination 
in Medical Settings (DMS) Scale exhibited good convergent validity as evidenced by 
significant positive correlations with the widely used Everyday Discrimination Scale 
(Peek, Nunez-Smith, Drum, & Lewis, 2011).  The DMS Scale was not statistically 
associated with a measure of social desirability (r=.18, p=.13) thus establishing 
discriminant validity.  In addition, the scale has a high degree of internal consistency 
(Cronbach's α= 0.89)(Peek, Nunez-Smith, Drum, & Lewis, 2011).  
Qualitative Interview Prompts 
     To elicit the participants’ lived experiences, the researcher asked probing questions 
and encouraged participants to share concrete examples of their struggles, if any, with 
everyday racism using the Interview Guide (see Appendix F).  Interviews took place in a 
private room.  The lengths of the interviews varied from 20 minutes to almost two hours 
depending on the participants’ answers and the number of people interviewed together.  
All participants were asked permission to audio record interviews.  None refused.  
Participants were given a $25 incentive for participating in the interview process.  Due to 
limited funds, no remuneration was given to those participants who only completed the 
survey. 
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     In order to ensure confidentiality, the researcher assigned an identification number to 
each transcription.  All interviews and transcriptions are kept on a password-protected 
computer.  Any data in the form of hardcopies are secured in a locked storage file. 
Analyses 
Qualitative Data Analysis.  The data management software NVivo 11 was used to code 
the data. The researcher analyzed the data using a CGT approach.  Since the disparity in 
medication adherence within the African American ESRD population is a phenomenon  
about which little is known, CGT approach  allowed for an in-depth understanding and 
iterative analysis of the data (Charmaz, 2006, 2011).  CGT is steeped in the constructivist 
philosophical paradigm, which maintains that no objective reality exists (Charmaz, 2006; 
Denzin & Lincoln, 2011; Guba & Lincoln, 1994; Mertens, 2010; Schwandt, 1994).  
Instead, realities are subjective and are actively constructed through social interaction 
(Charmaz, 2006; Denzin & Lincoln, 2011; Guba & Lincoln, 1994; Mertens, 2010; 
Schwandt, 1994).  Thus, individuals construct subjective meanings in order to understand 
their world.  These subjective meanings are steeped in historical understandings and 
current interactions with others (Creswell, 2013).  In the case of this research, everyday 
racism is also socially constructed.  CRT maintains that race is a social construct that was 
historically produced as a tool to oppress in the form of racism (Delgado & Stefancic, 
2012).   
     CGT data analysis includes collecting data, studying the data through memo writing, 
and coding the data (Charmaz, 2006).  Coding is the process of constantly comparing the 
data and constructing conceptual categories that emerge through this comparison 
(Charmaz, 2006).  In accordance with CGT methods, the data from the interview 
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transcripts, subsequent research memos, and reflexive journal were used to analyze the 
data into categories (Charmaz, 2006).  According to CGT methods, coding occurs in two 
phases: initial coding and focused coding.  The initial coding process was completed at a 
quick pace through a line by line examination of the data.  After the initial coding was 
complete, the researcher began the process of focused coding.  Focused coding involves 
finding the central codes and collapsing them and/or expanding them to make sense of 
the entire data set--in essence determining the major themes in the data.  The researcher 
spoke to the Chair of her committee about thoughts and gleanings and spent much time 
thinking and questioning the generated categories.  Codes were refined and merged and 
themes began to form.  To avoid bias during qualitative analysis, both supporting and 
disproving examples pertaining to the relationship between racism and medication 
adherence were categorized.  This process continued until data saturation occurred and 
theory was generated.   
Quantitative Analyses.  A negative relationship was hypothesized.  It was hypothesized 
that African American ESRD patients who reported high incidences of everyday racism 
in the healthcare system would report lower adherence to their medication regimen.   The 
null and alternative hypotheses are: 
Ho:  There is no statistically significant relationship between everyday racism in 
the healthcare system and medication adherence among African American ESRD 
patients. 
Ha:  There is a statistically significant negative relationship between everyday 
racism in the healthcare system and medication adherence among African 
American ESRD patients, thus r ˂ 0.  
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     In this one-tailed research hypothesis, everyday racism in the healthcare system is the 
independent variable, and medication adherence is the dependent variable.  Since the 
hypothesis is concerned with ascertaining the relationship between the two variables, the 
statistical test chosen for analysis was the Pearson’s correlation.  The Pearson’s 
correlation was chosen because it is used to determine the strength and direction of a 
linear relationship between two continuous variables.  In this study the two variables are 
MARS-5 and DMS scale.  The Pearson’s correlation test generates a coefficient called 
the Pearson’s correlation coefficient, r.  The correlation coefficient measures the strength 
and direction of a linear relationship between two continuous variables.  Its value can 
range from -1 for a perfect negative linear relationship to +1 for a perfect positive linear 
relationship (Tabachnick & Fidell, 2007).  A value of 0 (zero) indicates no relationship 
between two variables.   Prior to conducting the analysis, the level of significance was set 
at α = .05.  Therefore Ho (the null hypothesis) will be rejected only if p ≤ .05.   
     Data were entered into SPSS 24.  Categorical data were coded using dummy variables 
while continuous data were entered verbatim.  Frequency tables for all variables were 
generated to check for data input errors and missing data.  There were few missing data 
and it appeared to be missing at random as opposed to a pattern of missingness.   
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CHAPTER 4
FINDINGS      
     The purpose of this study was to explore the possible relationship between everyday 
racism and medication adherence among African American ESRD patients.  A mixed 
methods research study was conducted which was comprised of an exploratory 
qualitative study using constructivist grounded theory and a correlational quantitative 
study.  Both methods were informed by Critical Race Theory.  The specific aims of the 
qualitative study were to ascertain 1) Do African American ESRD patients experience 
everyday racism in the healthcare system? 2) If so, does everyday racism influence their 
medication adherence? 3) If so, in what way does everyday racism influence their 
medication adherence? 4) If not, what does influence their medication adherence?  The 
specific aim of the quantitative study was to ascertain if there was a relationship between 
everyday racism in the healthcare system and medication adherence among a 
convenience sample of African American ESRD patients. 
     This chapter provides an overview of participants, then presents research findings in 
two parts.  The qualitative portion of the study will be presented first followed by the 
quantitative portion of the study.   
Participants 
     The total study sample included 46 participants (see Table 4.1).  The semi-structured, 
in-depth interviews were conducted at two locations (AAKP, PEM) and a total of 27 
African American ESRD patients were interviewed.  After each qualitative interview, 
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each participant completed a quantitative questionnaire.  Additionally, 19 participants 
completed the questionnaire who were not interviewed.   
Table 4.1 Demographic and Descriptive Characteristics of All Participants (n=46) 
 
Characteristics                  n(%)   Mean (SD)            Median 
(range) 
Gender 
   Female                   23(50.0)      
  
   Male                   23(50.0)      
  
 
Age                              55.9(10.5)  55.0(44.0) 
 
Education       
Some High School                 8(18.2)       
Graduated High School/             21(47.7) 
GED              
Graduated College                     13(29.5)         
(Bachelor’s Degree)        
Completed Graduate Studies      2(4.5) 
(Master’s or Doctorate Degree)   
 
Insurance Primary 
   Public Aid/Medicaid     9(20.5) 
   State Renal Program     1(2.3) 
   Medicare       30(68.2) 
   Private Insurance      3(6.8) 
   Federal Primary VA     1(2.3) 
 
 
Insurance Secondary 
   Public Aid/Medicaid     3(6.8) 
   State Renal Program     1(2.3) 
   Medicare       3(6.8) 
   Private Insurance      20(45.5) 
   None Denoted      17(38.6) 
 
 
Daily Number of Pills                                                  10.7(5.5)                   10.0(19.0)
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     Fifty percent of the total sample is female and 50% is male.  The average age of 
participants is 55.9 years.  In addition 47.7% graduated high school or obtained their 
GED.  This is followed by 29.5% graduated college and 18.2% reported having 
completed some high school, and 4.5% completed graduate studies.  The primary mode 
of insurance for the sample is Medicare (68.2%), public aid/Medicaid (20.5%), private 
insurance (6.8%), state renal program (2.3%), and Federal Veteran’s Administration 
(2.3%).  Most participants indicated that private insurance (45.5%) served as their 
secondary mode of insurance.  Additionally, 38.6% of participants did not denote a 
secondary mode of insurance.  Participants stated that their secondary mode of insurance 
coverage was comprised of the following: Medicare (6.8%), Public aid/Medicaid (6.8%), 
and state renal program (2.3%).  Lastly, the average daily number of pills was 10.7 
(median=10.0; minimum=2; maximum=21). 
     Exploratory analyses indicated that the interviewed and non-interviewed groups did 
not differ on key variables including gender, age, education, insurance coverage type, and 
daily number of pills.  The results of the one-way ANOVA do not show an overall 
significant difference between the three groups with regard to the MARS-5 
(F(df=2,43)=.047, p= .954) and DMS scale (F(df=2,43)= .919, p = .407).   
Qualitative Themes 
     Experiences of Everyday Racism in the Healthcare System.  To explore the first 
research question regarding African American ESRD patients’ possible experience with 
everyday racism in the healthcare system, participants were asked if they were treated 
fairly in the healthcare system in general and the dialysis center in particular.  Several 
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participants articulated unfair treatment which they attributed to being African American.  
For example one male participant related,  
     “The first nephrologist that I had was African American.  And he had been a  
     nephrologist for a long time.  He tended to take more care with his African American  
     patients.  Because that was his culture.  The Caucasian nephrologist, I don’t think that  
      he, in fact I know he didn’t give me the same level of care.  And it could be due to  
     him seeing me as a race more than a dollar sign.” 
     When an elderly male participant who has been on dialysis for 30 years told me that 
he had experienced unfair treatment because of his race, he added, “They try to hide it. 
You know, because they can’t be obvious about it.”   
     When I queried further three themes of unfair treatment emerged: 1) concern that 
invasive procedures would be conducted unnecessarily 2) the fear of being treated 
without consent 3) different rules in dialysis clinics for Whites and African Americans.   
The following is a description of each of these themes 
     Concern regarding invasive procedures.  This theme relates to participants’ 
expressed concern that doctors were more likely to perform invasive procedures on 
African Americans than Whites, which some connected with the historical abuse of 
African Americans’ in the medicine.  For example, one male participant stated, 
    “ I have noticed amongst African American men and it's almost like when I go back to  
     look at the roots, most African American men in our clinics have their legs amputated.   
     Most of the White men do not.  It's almost like if you have a sore, cut it off. You have  
     a leg, cut it off.  You have some issue, cut it off but I've seen that amongst African  
     American men.  I don't see that amongst Caucasian men.  I don't see that.” 
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     Another participant spoke at length about his constant fear for two years that doctors 
were going to perform “cut up surgery” on his toes.  He explained that his toes looked 
strange but were fine because they had been like this for two years.  He asserted that he 
knew his body but every few months when the nurses examined his toes they would say, 
     “’It's bad. That's dark. You got to get that cut off.’  They put that in your head.  And 
     these were two Caucasian nurses that told me that.  ‘You got to go see doctor.  You  
     got to get them toes cut off. They don't look good.’  And they write it on the chart, 
     need to go see the doctor and amputation.  My toes ain't been cut off, yet.  This is from 
     two years.”  He went on to say, “They're quick to cut on African American people  
     because there's a way, you don't care no way.” 
     A few participants introduced the idea of African Americans being used as “guinea 
pigs” as a reason for the differential treatment.  As a female participant explained, 
     “But the thing that saved me, I got a Black African surgeon, Dr. B.  Those (other)  
     doctors, ‘Oh, Miss. D., we need to take your legs.’  Dr. B. came in there, he said ‘Miss  
     D.,’ he said, ‘don't let them cut your leg off.’  He said, ‘Y'all are guinea pigs.’”  
One male participant interjected,  
     “And with Black males, it goes so far back to so many things that the trust level  
     between Black males and doctors is not there.  So many instances where-- there's the  
     Tuskegee experiment.  There are so many evil things that have happened.” 
At that point another participant with anger in his voice concurred, 
     “But I do believe we get guinea pigged, we get cut on, we get experimented on,  
     because from what I understand and when I've been doing a little research they don't  
     consider African American people really citizens of the United States.  We can send  
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     everyone else back, but we can't send African American's because they ruined our  
     heritage. We can't go back to Africa.  We can't go back to where we come from so  
     we're here to stay.  But when you do the research, they still don't respect us and you  
     can tell by the treatment that we get. That's just the bottom line.”  
     Fear of treatment without consent.  The second theme that emerged is that 
participants felt that they were given treatment without their consent.  They believed that 
this usually happened to African Americans and explained that they had to be vigilant to 
make sure healthcare providers did not do something to them without their knowledge.  
As one participant stated,  
     “They always try to tell me, ‘Go to sleep.’”  Another participant agreed, “They always  
     tell me, ‘Ain’t you ready to go to sleep?’  I ain’t going to sleep.  I’ll go to sleep when I  
    get home.” 
A participant in another interview stated, 
     “Everybody (African Americans) told me when I started.  They were like, ‘Don't fall  
     asleep now. You better stay awake and watch,’ and everything.  And that's what I try  
     to do.  I try to stay awake. They (nurses) say, ‘why don't you lay back and go to sleep      
     and stuff?’  And I'm like, "No, I have to watch you all.” 
     Several participants recounted waking up while nurses were injecting medication into 
their IV.  One participant explained, “I’m like, Uh uh!  I said, I don’t know what this is. I 
ain’t taking that.”  Another participant recounted a time when she did go to sleep.  She 
stated,  
     “I was asleep, and I woke up, they had gave me some iron.  I know what iron is for.   
     But nobody told me my level was low or anything.  I told them, Stop, until you let me  
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    see the paperwork with what the level was.” 
Another participant angrily remembered a recent episode where she woke up to nurses 
administering medication she had no idea about.  
     “And like I asked yesterday, ‘What is this you're putting in me?’ at dialysis.  ‘Oh, it's  
     all right’ (said the nurse).  Yeah, Mother fucker, crazy.  No, it ain't all right.”  A male  
     participant agreed stating, “You (healthcare provider) want to continue to do  
     something without communicating.  They don't consult with you.  They don't give you  
     no time.” 
     Different rules.  A third theme emerged concerning the possible experience of 
everyday racism in the healthcare system among African American ESRD patients.  
During our discussions participants divulged that they saw White dialysis patients receive 
preferential treatment.  This treatment was in two forms: 1) some Whites were allowed to 
have family members sit with them during dialysis 2) some Whites were allowed to 
dialyze when they wanted.  Many participants complained that certain White dialysis 
patients were allowed to have family members sit with them during the dialysis process 
but they had never seen this extended to African Americans.  One participant explained 
that her daughter went with her during her first dialysis session.  She explained,  
     “It was new to me. I took my daughter.  But they let her sit beside me that day but  
     they said, ‘We don’t like people in here, because it’s violating other people’s rights.’ 
     However she noticed, “I know there was a White lady that, no, it was a man.  And his 
     daughter and, it would be like three of them would come with him.  But they never put 
     them out.” 
During another interview, a participant stated,  
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     “That one lady (White) who had the kids come and visit her all the time.”  She  
     continued saying that she never saw African Americans with family members in her  
     clinic.  When I asked why, she said she was told that it was not allowed, “but they  
     never put them out.” 
     Another part of this theme is the complaint that some Whites were allowed to dialyze 
when they wanted while African Americans were not afforded this privilege.  One 
participant angrily related, 
     “When it comes to race, I did feel like that at one point.  There was this one girl, a  
     White girl. We didn't know when she came because she was always there whenever  
     she felt like, she came.  But if I had an issue, where I'm literally - not because I'm not  
     coming or I don't fit - I'm in the hospital or I'm in the ER, and they've decided not to  
     admit me, I get a problem. This girl comes whenever she wants to.” 
Others described how their dialysis times were changed to less desirable times to 
accommodate Whites.  
     And then they took the White - they said something, like some of the White people  
     that was coming later - they just put them all in front of me.  So I'm like, "Oh, man."  
     they took my time and took it from 6:30 and skipped me all the way back to an hour,  
     to 7:30.”  Another participant stated, “But I noticed that they, Whites, all get to come  
     early.” 
     Attributions & Implications of Unfair Treatment.  Three themes emerged 
regarding unfair treatment attributed to race and its effect on medication and medication 
adherence: 1) Concern that medical providers were not knowledgeable about the 
medications they were prescribing 2) Concern that the medication was not safe 3) 
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Information about medication and lab results being withheld or given to participants 
without further consultation.  The results of these themes on their medication adherence 
were fourfold.  First, participants stated that they took less medication than prescribed or 
did not take their medication at all.  Second, participants explained that they stopped 
taking their prescribed medication and replaced them with alternative remedies such as 
herbs and vitamins.  Third, participants explicated that they choose a day every week 
where they do not take medications.  Some referred to this as a ‘vacation from 
medication’.  The rationale of this choice is that they would receive less of the negative 
effects of their medication if they took it fewer times each week.  Lastly, participants 
spoke of replacing and minimizing medication intake through self-directed changes in 
their diets.  For example, participants described decreasing their sodium, fat, phosphate, 
and sugar dietary intake.  Thus they felt that they could decrease the amount of 
medication they took daily without input from medical providers. 
     Concern about medical providers’ knowledge of medications.  The first theme 
concerning medications that participants articulated was a concern that medical providers 
were not knowledgeable about the medications they were prescribing and encouraging 
the participants to take.  This concern made some participants wary of taking the 
medication prescribed.  Thus some participants just did not take the medication or took 
less than was prescribed.  As example, one participant tearfully stated,  
     “If I ask you a question about my health and my medication, and you can't tell me,  
     what you're doing to me?  You're killing me because you're killing me mentally or  
     physically.”   
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     Another participant recounted a time when he was prescribed many medications by a 
nephrologist at his clinic.  He had severe complications because some of his drugs 
interacted.  As a result, he had to be hospitalized and sometimes did not take medication 
as prescribed because he was fearful of more problems.  He asserted, “If you give me a 
medication, you're a doctor, I want this doctor to know what you're giving me.” 
     Concern that the medications are not safe.  Another theme that emerged was the 
concern that the medications prescribed were not safe.  There was a sense amongst some 
participants that the medical community did not have their best interests in mind and this 
extended to the medication that they were prescribed.  As one participant stated,  
     “I mean, it's almost like we are the guinea pigs. We are being used as, ‘Well, let's try  
     this (medication),’ without consulting, without explaining, without being detailed.”  
Another lamented,  
     “Because I've found that the nurse comes up and puts stuff in my IV all the time, that  
     makes me sick.”   
Others felt that the medicine they are prescribed might work well with White people but 
were detrimental to African Americans.  One participant asserted,  
     “But you can't just take a generic medicine across the board.  This is affecting the  
     African American people.  This is what's better for you (White person), this is what  
     she used, that's what she used, I'm going to prescribe this to you and your body rejects  
     it.  Yes, I think they’re medicines that are generic and we're guinea pigs.  Yeah, I do 
     believe.  ‘Well, this is what everybody else takes.’  But everybody’s body is not the  
     same.”  
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     Differential treatment regarding information.  The last theme is that information 
about medication and lab results were withheld or given to participants without further 
consultation.  In contrast, White patients received in-depth consultation.   As one 
participant stated, 
     “Because the dietitian where I’m at, she will go in really detailed depth detail with a  
     White person and she won’t go in detail too much with me.”  
Another explained,  
      “But sometimes when you (medical provider) go to one of the White patients you’ll  
     tell them why.  You’ll sit and explain it to them, but some of us you’re just passing us  
     by giving us a sheet saying, okay da dada and that’s it.”    
Another echoed,  
     “And they don’t tell you everything.  Then another PA [physician assistant] come  
     through, ‘Well, you know you have blood pressure issues?’ Or ‘Your cholesterol was  
     high this time,’ or ‘You're taking this,’ or ‘I'm going to put you on this.’  Well, the  
     doctor just left here and he didn’t tell me nothing.  ‘Don’t you know your cholesterol  
     is elevated?’  "No.’ They don't go through and fine-tune your thing, they rush through 
    it.” 
Yet another stated,  
     “No.  It's almost like they're not there, they just check in with you and move on.” 
     The overall sentiment from the participants who described unfair treatment attributed 
to race and its effect on medication adherence was that their opinion and concerns were 
disregarded.  As explained by a participant,  
     “Well, if you don't consent to taking this medicine, they done gave you anything.  And  
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     then, if I got a White lady sitting beside me, you could hear them explaining to her  
     what this medicine is.” 
Thus if the participants had concerns about their medication, they were given another 
medication without proper consultation.  Then they witnessed White patients given much 
consultation just after the physician left them.  Therefore, the participants felt neglected 
and ignored by their medical providers which in turn made them wary of the medication 
prescribed.  It also made them wary of the source of the medication information.  Hence 
some participants explained that they did not trust their medical providers’ directives and 
turned to the White patients in their dialysis centers instead for medication information.  
Then they took this information to their medical providers and advocated for the 
medication the White patients were receiving.  One participant stated,  
     “I've got more good information from P. (patient) than any doctor, any clinic, he gave  
     me more good information than anybody.”  
     When asked why they thought that medical providers were not giving them the best 
medication information, participants cited three reasons.  The participants explained 
when asked that the reason for the differential treatment was usually based on their race.  
First, they stated that they felt the medical establishment viewed them as ignorant.  Even 
a participant who had a doctorate in physics explained that she was viewed as ‘stupid’ 
until she began using medical terminology and verbalizing an understanding of her 
kidney disease.  Second, several participants explained that medical providers seemed to 
have the perception that they were ‘better’ than them.  Patients felt that they were “less 
than” the providers and that this was exacerbated by race.   
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     Lastly, some African American male participants explicated that medical providers 
appeared afraid of them because of their race.  One participant tearfully recounted an 
incident where the White nephrologist called the local police to detain him.  He explained 
that he showed up the day he was scheduled for dialysis and the receptionist said he had 
the date wrong.  He protested and the nephrologist disagreed with him.  He refused to 
leave because he was due for dialysis, so the nephrologist called the police.  The 
participant explained that he felt so humiliated and discounted but had to continue going 
to the clinic because he has no ability to travel to another clinic.   
     Other Contributors to Medication Adherence.    For those participants who did not 
articulate racism as a barrier to their medication adherence, the researcher explored what 
barriers the participants experienced.  Participants gave several reasons why they had 
difficulty adhering to their medication regimen.  Some explained that the timing of taking 
medications just did not work for them.   
     “The way the doctors wanted me to do it, I couldn’t adhere to that schedule. It was just  
     too difficult because you know, I had two pills that they wanted me to take three times  
     a day.  And then I had a couple pills they wanted me to take four times a day.” 
Others explained that since they often have to take medicine with meals that going out to 
eat sometimes leads to missed doses.  
     “But that’s the hardest thing for me is when I go out to eat, and I like to eat out.  But  
     like today I went for lunch, and I couldn’t find my pills, and I was like, ‘Ugh! OK.’” 
Another participant echoed this.  
     “So you know, we make sure at dinner we’ll take them, but I don’t, but I knew I had  
     put them in my bag, but I don’t know what happened. Something happened.” 
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     Others complained that the side effects of the medication resulted in them missing 
doses.  “So it just goes from one side effect to another, and the side effects are worse than 
what you’re trying to fight.”  While some participants explained that they did not think 
the medicine was helping them in anyway because they didn’t “feel the effects of it.”  
Lastly, participants related that it was simply difficult to remember to take their 
medication because they were busy.  “I might mess around.  I might be here.  I might be 
there.  I might mess around and go out of town.  So I might mess around and miss a 
treatment, miss taking my medicine.”  Being busy with life was often combined with the 
sentiment that there were so many pills to take.  “And it was just, I had to set my alarm 
on my phone in order to remember when to take all these medications.” 
Quantitative Results 
     The purpose of the quantitative study was to ascertain if there was a statistically 
significant relationship between everyday racism in the healthcare system (DMS) and 
medication adherence (MARS-5).  Since there is not an overall significant difference 
among the three groups with regard to the MARS-5 and DMS scale, the groups were 
combined (N=46) for analysis using the Pearson’s correlation.  The results of the 
Pearson’s correlation show a significant negative relationship (r = -.477, p < .01) between 
medication adherence and everyday racism in the healthcare system, so the null 
hypothesis was rejected.  In other words, participants who have lower medication 
adherence report experiencing more everyday racism in the healthcare system.  
Furthermore, the independent variable, everyday racism in the healthcare system explains 
23% (-.477)
2
 of the variance in medication adherence.  According to Cohen (1988), a 
correlation coefficient between .30 and .49 is considered moderate correlation.  
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     Follow-Up Question for each item of the DMS Scale.  As part of the DMS scale, 
there is a the follow-up question that is included in the original Everyday Racism Scale 
from which the DMS scale is based (Williams, Yu, Jackson & Andersen, 1997).. The 
DMS scale applies the construct, everyday racism, specifically to the health care system.  
The original Everyday Racism Scale included a follow-up question after each survey 
item.  For example, if participants denote that they experienced everyday racism, they are 
prompted with: “What do you think was the main reason for this experience?”  Table 4.2 
shows frequencies for participant responses to each survey question.
  
 
6
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Table 4.2: Follow-Up Questions for Each Item of DMS Scale (n=46) 
Question                                                                                            Main Reason n(%) 
                                                       Race      Age       Other Aspect    Gender     National      Education/     Weight    
                                                                                   of Physical                        Origin/         Income      
                                                                                   Appearance                       Ancestry      Level 
Treated with less courtesy           8(17.4)    3(6.5)       4(8.7)              3(6.5)         ___             2(4.3)             1(2.2)         
 
Treated with less respect             7(15.2)    3(6.5)       3(6.5)              2(4.3)         ___             1(2.2)             2(4.3)        
 
Receive                                        5(10.9)    2(4.3)       2(4.3)              2(4.3)        1(2.2)          1(2.2)              ___              
poorer service  
 
Doctor/nurse acts                         9(19.6)    2(4.3)       3(6.5)              2(4.3)         ___             2(4.3)            1(2.2)           
as if he or she thinks 
you are not smart 
 
Doctor/nurse acts                        5(10.9)     ___           1(2.2)             1(2.2)        1(2.2)           1(2.2)             ___     
as if he or she is  
afraid of you 
 
Doctor/nurse acts                         4(8.7)      2(4.3)       2(4.3)              2(4.3)         ___            4(8.7)              ___              
as if he or she is      
better than you 
 
Feel like a doctor/                        4(8.7)      1(2.2)       2(4.3)             3(6.5)          ___             5(10.9)          1(2.2)  
nurse is not listening  
to what you were saying 
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CHAPTER 5 
DISCUSSION 
     The intent of this study was to examine the possible relationship between everyday 
racism in the healthcare system and medication adherence among African American 
ESRD patients attending two patient-centered conferences.  This was investigated by 
exploring the perceptions and experiences of participants’ treatment within the healthcare 
system through individual and group in-depth interviews.  In addition, participants 
completed surveys regarding medication adherence and everyday racism in the healthcare 
system.  The following is a discussion of findings.  Included are a summary of the study 
and convergence of mixed methods, strengths and limitations of the study, as well as, 
implications of study for social work through a CRT lens, and recommendations for 
future research are addressed. 
Summary of Study & Convergence of Mixed Methods 
     A mixed methods research study is beneficial when there is scant knowledge in the 
extant literature about a phenomenon such as the possible effect of everyday racism 
within the healthcare system on medication adherence in the ESRD African American 
population.  A mixed methods study also provides a more comprehensive account of the 
studied phenomenon leading to an increased credibility of findings (Creswell & Clark, 
2011).   Furthermore, a mixed methods study allows the researcher the ability to ascertain 
if the two forms of research converge or diverge (Creswell & Clark, 2011).   
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     This research study has led to a more comprehensive understanding of the relationship 
between everyday racism in the healthcare system and medication adherence within the 
sample of African American ESRD studied.   Four research questions were explored for 
the qualitative portion of the study:  
 1) Do African American ESRD patients experience everyday racism in the    
     healthcare system?   
2) If so, does everyday racism influence their medication adherence?   
3) In what way does everyday racism influence their medication adherence? 
4) If everyday racism is not a barrier to medication adherence, what is?  
     In response to the first question, three themes of unfair treatment emerged: 1) concern 
that invasive procedures would be conducted unnecessarily 2) the fear of being treated 
without consent 3) different rules in dialysis clinics for Whites and African Americans.  
In response to the second and third question, three themes emerged from the in-depth 
interviews regarding unfair treatment attributed to race and its effect on medication and 
medication adherence: 1) Concern that medical providers were not knowledgeable about 
the medications they were prescribing 2) Concern that the medication was not safe 3) 
Information about medication and lab results being withheld or given to participants 
without further consultation while White patients received consultation. 
     When asked, the participants explained that these three themes did influence their 
medication adherence.  Participants stated that they took less medication than prescribed 
or did not take their medication at all.  Participants also stated that they stopped taking 
their prescribed medication and replaced them with alternative remedies such as herbs 
and vitamins.  Some participants explicated that they choose a day every week where 
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they do not take medications.  Some referred to this as a ‘vacation from medication’.  The 
rationale of this choice is that they would receive less of the negative effects of their 
medication if they took it fewer times each week.  In addition, participants spoke of 
replacing and minimizing medication intake through self-directed changes in their diets.  
For example, participants described decreasing their sodium, fat, phosphate, and sugar 
dietary intake.  Thus they felt that they could decrease the amount of medication they 
took daily without input from medical providers. 
     Lastly, participants gave several reasons for their medication nonadherence that are 
not related to everyday racism.  Participants explained that the schedule for taking their 
medications that was delineated by their medical provider was too difficult for them to 
maintain.  Others explained that since they often have to take medicine with meals that 
going out to eat sometimes leads to missed doses.  Participants also complained that the 
side effects of their medication were so harsh that they missed doses.  Some participants 
insisted that they did not feel any effects from taking their medication, so they did not see 
the utility in taking them as prescribed.  Finally, participants stated that they led really 
busy lives and it was difficult to remember to take their medication.   
     Because this is a mixed methods research study, it is important to ascertain if the 
qualitative and quantitative results converge and support one another or diverge.  In this 
study, the qualitative and quantitative results converge.  It was hypothesized that there 
would be a statistically significant negative relationship between everyday racism in the 
healthcare system and medication adherence among the African American ESRD patients 
sampled.  Indeed there was a significant negative relationship (r = -.477, p < .01) between 
medication adherence and everyday racism in the healthcare system.  According to 
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Cohen (1988), a correlation coefficient between .30 and .49 is considered moderate 
correlation.  In other words, participants who reported lower medication adherence also 
reported experiencing more everyday racism in the healthcare system.  Furthermore, the 
independent variable, everyday racism in the healthcare system explains 23% (-.477)
2
 of 
the variance in medication adherence.   
     Additional convergence of the quantitative portion of the study with the qualitative 
portion of the study is evident in the responses of the follow-up questions within the 
DMS scale.  Race was given as the main reason for discriminatory treatment denoted by 
participants for five of the seven questions.  For the sixth question, A doctor or nurse acts 
as if he or she is better than you, Race and Education or Income level were the most 
frequent reason chosen at 8.7% .  The final question, You feel like a doctor or nurse is not 
listening to what you were saying, was most frequently attributed to Education or Income 
level (10.9%).  This was followed by Race (8.7%).  Thus the quantitative data supports 
the information gleaned during the in-depth interviews giving further credence to the 
qualitative findings.  
Strengths and Limitations 
     There are three main strengths of this study.  First, this is the first study to explore 
medication adherence within the ESRD population qualitatively.  Second, this is the first 
study which explores everyday racism’s impact in general on African American ESRD 
patients and specifically in relation to medication adherence within the nephrology 
literature base.  Up until this point, the race of research participants was noted in 
quantitative studies, but no examination of racism has occurred.  Lastly, critical race 
theory (CRT) has never been used as a theoretical framework for nephrology research.  In 
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fact, CRT has rarely been used as a theoretical lens for public health research.  Ford and 
Airhihenbuwa (2010) implore public health social scientists to consider the theoretical 
implications of CRT as a conceptual foundation for health research.  The authors argue 
CRT provides a theoretical basis for scholars conducting public health research in the 
area of race equity.  Therefore, this study provides new insights regarding medication 
adherence in the African American ESRD population using a theoretical perspective 
relatively recent to public health research. 
     In addition to the strengths, there are several limitations of this study.  The qualitative 
portion consisted of in-depth interviews using convenience sampling while the 
quantitative portion is a nonexperimental, cross sectional design with convenience 
sampling.  First, although we can determine an association between the independent and 
dependent variable, it is difficult to determine the temporal relationship.  We cannot be 
sure that the variation in the dependent variable occurred after the variation in the 
independent variable.  The qualitative portion for those participants who were 
interviewed did allow for an investigation of time order.  In fact, several interviewed 
participants did relate that racism influenced their medication taking.  However, the 
research design is not rigorous enough to make such assertions overall.  
     Second, spuriousness may also be a factor given the research design.  Therefore, the 
association between the independent variable and the dependent variable might be the 
result of some other extraneous variable(s) which were not included in the study.  
Conducting a more expansive study which also includes other known variables which 
have been shown to impact medication adherence would provide a stronger argument for 
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the association between medication adherence and everyday racism in the healthcare 
system.   
     Third, this study relied on self-reports of the independent and dependent variables.  
Thus the participants could have provided socially desirable answers to the survey 
questions.  For example they could have reported that they were more adherent to their 
medications than they really are.  One way to alleviate this concern would be to verify 
medication adherence with patient records.  This necessitates approval from the 
corporations that own most dialysis clinics.  It is very difficult to obtain permission to 
conduct research in the mostly privately owned dialysis clinics.  Another way to address 
this limitation would be a study involving prolonged engagement with participants.  
Medication adherence could then be measured over time using a measuring device such 
as the medication event monitoring system (MEMS).  MEMS electronically measures 
each time a medicine container is opened and closed. 
     Fourth, generalizability is also problematic in this study.  Participants were sampled 
from two patient-centered conferences.  Those who participated in the study may be quite 
different from the larger population of African American ESRD patients.  Conducting the 
study at a dialysis unit or a group of dialysis units would ameliorate this limitation.   
     However, it is important to note that even though there are several limitations 
regarding the study, this is the first study to ever examine the impact of everyday racism 
on medication adherence within the African American ESRD population.  Furthermore, 
these results both qualitatively and quantitatively suggest that everyday racism does 
impact the participants in the sample.  Thus further study is needed to explore this 
phenomenon in greater detail.  Lastly, this dissertation is an important contribution to the 
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extant nephrology medication adherence literature base.  These findings may lead to 
innovative interventions and further studies which can result in increased medication 
adherence within the African American ESRD population. 
Implications of Study for Social Work Through A CRT Lens 
     Medication nonadherence within the African American ESRD population is poorly 
understood and results in increased mortality, hospitalizations, and decreased quality of 
life.  This mixed methods research study using CRT resulted in a greater understanding 
of the effect of racism on the ability of African American ESRD patients to manage their 
medication regimens through qualitative interviews.  In addition, the research found a 
statistically significant negative correlation between medication adherence and everyday 
racism within the healthcare system.  The following is a discussion of the implications of 
this research for social work and their relation to CRT.   
     The foundational core of CRT is that research leads to social action to address racism.  
One type of social action is in the form of intervention.  Every dialysis patient has a 
social worker to help them ameliorate the psychosocial barriers to treatment outcomes, 
including medication nonadherence.  Thus the results of this study can serve as the 
impetus of nephrology social workers to have discussions with African American ESRD 
patients about race and racism, including within their dialysis unit.  As explicated by 
CRT, Whites are loath to acknowledge the existence of racism in our society.  Therefore 
such discussion rarely occurs.  Social workers who are trained in diversity and cultural 
humility can be equipped to facilitate and engage in discussions about racism in the 
healthcare system. 
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     In addition, social workers are ethically bound to promote and work towards a core 
value of the social work profession, social justice.  According to the National Association 
of Social Workers (NASW, 2008), social justice entails “access to needed information, 
services, and resources; equality of opportunity; and meaningful participation in decision 
making for all people” (p. 3).  Furthermore, social workers are ethically bound to 
challenge social injustice in any form including racial oppression (NASW, 2008).  This 
research has provided evidence that participants experience racism in the healthcare 
system.  Once an injustice is acknowledged, efforts can be made to confront and eradicate 
the injustice.  Social workers can do this by beginning the conversation in their local 
dialysis clinics.  
     In the post-civil rights era of “color blind racism,” talk of race or racism may be 
avoided by Whites in public (Bonilla-Silva, 2002).  Therefore honest conversations with 
dialysis staff and healthcare providers facilitated by social workers about racism may also 
lead to positive change within dialysis clinics.  This could result in changes in the 
interactions among staff and African American dialysis patients in general and 
specifically in regards to medication adherence.  Such conversations could also lead to 
anti-racist, culturally relevant interventions with staff and healthcare providers that could 
be disseminated to other dialysis patients and centers. 
Recommendations for Future Research 
     Given this study, it appears that everyday racism within the healthcare system has an 
impact on medication adherence for the participants sampled and further research is 
warranted.  First, a quantitative study in which the DMS and MARS-5 are administered 
to a larger sample would be beneficial.  A larger quantitative study would be especially 
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helpful with the implementation of a more rigorous design such as a randomized control 
design.  Such a design would enable generalization of results to the broader population.   
To achieve such a design would necessitate sampling from several dialysis clinics or a 
large hospital affiliated dialysis unit.   
     Second, a comparison study involving patients from the Northern US and Southern 
US would be interesting to conduct.  It is possible that everyday racism is experienced 
differently in the Northern US and impacts medication adherence differently or not at all.  
Third, a more extensive quantitative study could be conducted.  A study which includes 
all of the variables explicated in the literature which affect medication adherence such as 
health beliefs, depression, and social support.  Collecting data on these variables as well 
as everyday racism in the healthcare system and statistically determining if they are 
predictors of medication nonadherence using multiple regression would be a helpful 
contribution to the existing knowledge base.  Lastly, a longitudinal study which follows 
participants over time to ascertain the impact of everyday racism within the healthcare 
system on their medication taking could provide interesting information.  It is possible 
that everyday racism affects one differently given one’s position in their dialysis 
trajectory.  For example, maybe everyday racism has a cumulative effect and those who 
are exposed to it longer in the dialysis center (more years on dialysis) are less adherent 
than those who have been exposed to it less (fewer years on dialysis). 
Conclusion 
     In conclusion, this dissertation explores the relationship between medication 
adherence and everyday racism among a sample of African American ESRD patients.  
Prior research suggests that African Americans have poorer rates of medication 
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adherence when compared to Whites.  However, the reasons for this racial inequity are 
not understood.  This is particularly troubling since ESRD patients who do not adhere to 
their medication regimes suffer decreased quality of life, increased morbidity, and death.  
     Several participants did indeed explain during in-depth interviews that they 
experienced everyday racism within the healthcare system.  Furthermore, this 
experienced everyday racism did negatively impact their medication adherence.  The 
results of the quantitative analysis support the qualitative accounts.  There was a 
statistically significant negative correlation between everyday racism in the healthcare 
system and medication adherence.  Additionally, race was denoted as the main reason for 
discrimination experienced in the healthcare setting in six of the seven DMS scale 
follow-up questions.  Thus everyday racism within the healthcare system and its impact 
on medication adherence within the African American ESRD population deserves further 
study. 
     To date, this is the only study that has been conducted with African American ESRD 
patients to understand the mediation adherence racial inequity.  This study and studies 
concerning racial health inequities have particular salience for the social work profession.  
Social workers are ethically bound to combat social injustice.  Racism in any form is a 
social injustice.  Therefore the further examination of injustice reported by participants in 
this study is a social work imperative.  Only through such examination can change occur.  
Thus this study is a first step in understanding how racism may impact the medication 
taking of African American ESRD patients.  It is clear that everyday racism did play a 
role in the medication adherence of the participants in this study.  Hence, further inquiry 
is warranted to understand the phenomenon more fully so interventions can be designed 
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and implemented to address the social injustice. 
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APPENDIX A
MEDICATION ADHERENCE REPORTING SCALE 
 
1. I forget to take my medication  
 ○ Always        ○Often         ○Sometimes        ○Rarely        ○Never 
 
2. I change the dosage of my medication 
 ○ Always        ○Often         ○Sometimes        ○Rarely        ○Never 
 
 3. I stop taking my medication for a while 
 ○ Always        ○Often         ○Sometimes        ○Rarely        ○Never 
 
 4. I decide to skip one of my medication dosages 
 ○ Always        ○Often         ○Sometimes        ○Rarely        ○Never  
 
 5. I use my medication less than is prescribed  
 ○ Always        ○Often         ○Sometimes        ○Rarely        ○Never 
 
The MARS-5 sum score was calculated by summing scores from each individual 
question (range = 5-25). Higher scores indicate higher self-reported adherence.
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APPENDIX B
 
DISCRIMINATION IN MEDICAL SETTINGS SCALE 
 
1. You are treated with less courtesy than other people.  
○ Always        ○Most of the Time        ○Sometimes        ○Rarely        ○Never 
 
2. You are treated with less respect than other people. 
 ○ Always        ○Most of the Time        ○Sometimes        ○Rarely        ○Never 
 
3. You receive poorer service than others.  
○ Always        ○Most of the Time        ○Sometimes        ○Rarely        ○Never 
 
4. A doctor or nurse acts as if he or she thinks you are not smart.  
○ Always        ○Most of the Time        ○Sometimes        ○Rarely        ○Never 
 
5. A doctor or nurse acts as if he or she is afraid of you.  
○ Always        ○Most of the Time        ○Sometimes        ○Rarely        ○Never 
 
6. A doctor or nurse acts as if he or she is better than you.  
○ Always        ○Most of the Time        ○Sometimes        ○Rarely        ○Never 
 
7. You feel like a doctor or nurse is not listening to what you were saying. 
○ Always        ○Most of the Time        ○Sometimes        ○Rarely        ○Never 
 
The DMS sum score is calculated by summing scores from each individual question 
(range = 7-35). Higher scores indicate higher self-reported discrimination in the medical 
setting.
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APPENDIX C 
SURVEY
Thank you for taking part in this survey. Please answer the following 
 
1. What is your Gender? (Circle one) 
 Female Male 
 
 
2. Age: ________years 
 
 
3. Please specify your ethnicity. (Circle one) 
 Black or African American 
 White 
 Hispanic or Latino 
 Native American or American Indian 
 Asian / Pacific Islander 
 Other 
 
 
4. What is the highest level of education you’ve completed? (Circle one) 
 Some high school [9-11 years] or less 
 Graduated high school/GED 
 Graduated college (Bachelor’s Degree) 
 Completed Graduate Studies (Master’s or Doctorate Degree) 
  
 
5. What insurance do you use to pay for your healthcare? Check all that apply, indicate if 
it is primary, secondary 
 Primary? Secondary? 
Public Aid/Medicaid    
State Renal Program    
Medicare    
Private insurance    
None    
 
 
6. Number of pills taken daily for dialysis: _______________pills
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Please answer the following questions based on your personal experience. There are 
no right or wrong answers. Please circle your response. 
 
1. I forget to take my medication  
  Always        Often         Sometimes        Rarely        Never 
 
2. I take a different dosage of my medication than my doctor prescribes 
  Always        Often         Sometimes        Rarely        Never 
 
 3. I stop taking my medication for a while 
  Always        Often         Sometimes        Rarely        Never 
 
 4. I decide to skip one of my medication dosages 
  Always        Often         Sometimes        Rarely        Never  
 
 5. I use my medication less than is prescribed  
  Always        Often         Sometimes        Rarely        Never 
 
 
Please answer the following questions based on your personal experience when 
receiving treatment for your kidney disease.  Please think about your interactions at 
your dialysis clinic, during other doctor’s visits and hospital visits outside of your 
dialysis clinic. There are no right or wrong answers. Please circle your response.   
 
When receiving treatment for your kidney disease: 
1. You are treated with less courtesy than other people.  
  Always        Most of the Time        Sometimes        Rarely        Never 
 
If you answered Always, Most of the Time, Sometimes, or Rarely, what do you think 
was the main reason for this experience?  Please circle your response: 
 
a. Your Ancestry or National Origins  
b. Your Gender 
c. Your Race 
d. Your Age  
e. Your Religion  
f. Your Height  
g. Your Weight  
h. Some other Aspect of Your Physical Appearance 
i. Your Sexual Orientation  
j. Your Education or Income Level 
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2. You are treated with less respect than other people. 
   Always        Most of the Time        Sometimes        Rarely        Never 
 
If you answered Always, Most of the Time, Sometimes, or Rarely, what do you think 
was the main reason for this experience?  Please circle your response: 
 
a. Your Ancestry or National Origins  
b. Your Gender 
c. Your Race 
d. Your Age  
e. Your Religion  
f. Your Height  
g. Your Weight  
h. Some other Aspect of Your Physical Appearance 
i. Your Sexual Orientation  
j. Your Education or Income Level 
 
 
3. You receive poorer service than others.  
  Always        Most of the Time        Sometimes        Rarely        Never 
 
If you answered Always, Most of the Time, Sometimes, or Rarely what do you think 
was the main reason for this experience?  Please circle your response: 
 
a. Your Ancestry or National Origins  
b. Your Gender 
c. Your Race 
d. Your Age  
e. Your Religion  
f. Your Height  
g. Your Weight  
h. Some other Aspect of Your Physical Appearance 
i. Your Sexual Orientation  
j. Your Education or Income Level 
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4. A doctor or nurse acts as if he or she thinks you are not smart.  
  Always        Most of the Time        Sometimes        Rarely        Never 
 
If you answered Always, Most of the Time, Sometimes, or Rarely, what do you think 
was the main reason for this experience?  Please circle your response: 
a. Your Ancestry or National Origins  
b. Your Gender 
c. Your Race 
d. Your Age  
e. Your Religion  
f. Your Height  
g. Your Weight  
h. Some other Aspect of Your Physical Appearance 
i. Your Sexual Orientation  
j. Your Education or Income Level 
 
 
5. A doctor or nurse acts as if he or she is afraid of you.  
  Always        Most of the Time        Sometimes        Rarely        Never 
 
If you answered Always, Most of the Time, Sometimes, or Rarely, what do you think 
was the main reason for this experience?  Please circle your response: 
 
a. Your Ancestry or National Origins  
b. Your Gender 
c. Your Race 
d. Your Age  
e. Your Religion  
f. Your Height  
g. Your Weight  
h. Some other Aspect of Your Physical Appearance 
i. Your Sexual Orientation  
j. Your Education or Income Level 
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6. A doctor or nurse acts as if he or she is better than you.  
  Always        Most of the Time        Sometimes        Rarely        Never 
 
If you answered Always, Most of the Time, Sometimes, or Rarely, what do you think 
was the main reason for this experience?  Please circle your response: 
 
a. Your Ancestry or National Origins  
b. Your Gender 
c. Your Race 
d. Your Age  
e. Your Religion  
f. Your Height  
g. Your Weight  
h. Some other Aspect of Your Physical Appearance 
i. Your Sexual Orientation  
j. Your Education or Income Level 
 
 
 
7. You feel like a doctor or nurse is not listening to what you were saying. 
  Always        Most of the Time        Sometimes        Rarely        Never 
 
If you answered Always, Most of the Time, Sometimes, or Rarely, what do you think 
was the main reason for this experience?  Please circle your response: 
a. Your Ancestry or National Origins  
b. Your Gender 
c. Your Race 
d. Your Age  
e. Your Religion  
f. Your Height  
g. Your Weight  
h. Some other Aspect of Your Physical Appearance 
i. Your Sexual Orientation  
j. Your Education or Income Level  
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APPENDIX D
 
INFORMED CONSENT LETTER 
AFRICAN AMERICAN END-STAGE RENAL DISEASE PATIENTS AND MEDICATION 
ADHERENCE: WHAT ARE THE EFFECTS OF EVERYDAY RACISM 
      Thank you for agreeing to participate in this study.  The purpose of this study is to 
ascertain the meaning that African American ESRD patients may ascribe to the effects of 
everyday racism within the healthcare system on their ability to adhere to their 
medication regimens. You are being asked to participate in this study because you are an 
African American End-Stage Renal Disease patient. This study is being conducted by 
Tamara Savage, a doctoral candidate, and Dr. Teri Browne from the College of Social 
Work at the University of South Carolina 
      There are two parts of the study.  The first part is an interview will last for 
approximately 1 hour.  If you consent, the interview will be tape recorded.  The second 
part is a 10 minute survey.  Your participation is voluntary and you can end your 
participation at any time.  Furthermore, you do not have to answer any questions that you 
do not want to.  There is no cost to you to take part in this study. In addition, your 
responses are confidential, and any information that you share will be kept confidential 
by the researchers.  No names will be mentioned in the final report.  You may choose not 
to take part or quit the interview at any time at no penalty to you.  You will receive $25 
as a thank you for helping us understand the possible role of everyday racism within the 
healthcare system in the medication adherence of African American ESRD patients.  
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     If you have questions now or during the session, please ask. If you have any questions 
after the interview, please call Tamara Savage at (910)-620-3002. Also, if you have 
questions later, you can also contact:  
Dr. Teri Browne 
College of Social Work 
University of South Carolina 
Columbia, SC 29208 
(803) 777-6258, browne@sc.edu 
 
You can keep this consent letter for your records and future reference. Thank you in 
advance for your help with my study!
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APPENDIX E 
INFORMED CONSENT LETTER-SURVEY ONLY 
AFRICAN AMERICAN END-STAGE RENAL DISEASE PATIENTS AND MEDICATION 
ADHERENCE: WHAT ARE THE EFFECTS OF EVERYDAY RACISM 
 
      Thank you for agreeing to participate in this study.  The purpose of this study is to 
ascertain the meaning that African American ESRD patients ascribe to the effects of 
everyday racism within the healthcare system on their ability to adhere to their 
medication regimens. You are being asked to participate in this study because you are an 
African American End-Stage Renal Disease patient. This study is being conducted by 
Tamara Savage, a doctoral candidate, and Dr. Teri Browne from the College of Social 
Work at the University of South Carolina 
      The study consists of a 5-10 minute written survey.  Your participation is voluntary 
and you can end your participation at any time.  Furthermore, you do not have to answer 
any questions that you do not want to.  There is no cost to you to take part in this study.  
In addition, your responses are anonymous, and any information that you share will be 
kept confidential by the researchers.  No names will be collected and there will be no way 
to match any individual with given responses.   
     If you have questions now or while filling out the survey, please ask.  If you have any 
questions after completing the survey, please call Tamara Savage at (910)-620-3002. 
Also, if you have questions later, you can also contact:  
Dr. Teri Browne 
College of Social Work 
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University of South Carolina 
Columbia, SC 29208 
(803) 777-6258, browne@sc.edu 
 
You can keep this consent letter for your records and future reference. Thank you in 
advance for your help with my study!
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APPENDIX F
 
INTERVIEW GUIDE 
 
INTRODUCTION (10 minutes) 
1. Thank you for agreeing to be interviewed. I would like to talk to you about your 
experiences with the medical system, including things like the medications 
prescribed for you, doctor’s recommendations, how you are treated by medical 
staff, and so on.. 
2. Review consent letter. Ask for questions and obtain signature if participant agrees 
to participate.  
3. Ask if it is alright to audio tape. If so, begin taping. If not, take notes. 
 
QUESTIONS (30 to 50 minutes) 
1. Dialysis patients often have to take medications daily. What is it like for you? 
[Prompts:] 
a) What is a typical day like for you when it comes to taking your 
medications? 
b) What about other days that are not so typical? What are atypical days like 
for you when it comes to taking your medications? 
 
2. The medical field often defines medication adherence as taking medication as 
your doctor prescribes. What are your thoughts about taking your medication like 
your doctor prescribes? [Prompts:] 
a) What problems do you experience?  
b) What gets in the way of taking your medication as prescribed? 
c) What successes do you experience? 
d) What helps you take your medication as prescribed? 
 
3. Generally speaking, how are you treated in the healthcare system (by doctors, 
nurses, pharmacists)? [Prompts:] 
a) Do you believe you are treated fairly or unfairly? 
b) If so, what do you think explains this different treatment you receive?  
c) Can you give me some examples? 
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4. How are you treated when you express your medical concerns to doctors, nurses, 
pharmacists? [Prompts:] 
a) Do you believe you are treated fairly or unfairly? 
b) If so, what do you think explains this different treatment you receive?  
c) Can you give me some examples? 
 
5. When you think about your dialysis unit, how are you treated? [Prompts:] 
-How do you feel you are treated by the dialysis staff (doctors, nurses, 
dietitian, dialysis technicians, social workers)?  
a) Do you believe you are treated fairly or unfairly? 
b) If so, what do you think explains this different treatment you receive?  
c) Can you give me some examples? 
 
       -How are your medical concerns treated by dialysis staff (doctors, nurses,  
             dietitians,  dialysis technicians, social workers)? [Prompts:] 
a) Do you believe you are treated fairly or unfairly? 
b) If so, what do you think explains this different treatment you receive?  
c) Can you give me some examples? 
 
6. When you think about those occurrences of racism (if the participants have 
articulated racism) in the healthcare system including your dialysis unit, how does 
it or does not affect your medication adherence? Does it play a role in your 
medication taking? [Prompts:] 
a) How are you treated when you ask questions about your medications? 
b) How are you treated if your labs results indicate that you are struggling 
with medication adherence? 
c) Do you think you are given the information about your medication and 
labs that you need? 
 
7. Now that you know what the research is about, is there anything that I should 
have asked but didn’t? 
 
ADMINISTER SCALES (5 to 10 minutes) 
 
